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One of the earliest sub-clinical stages associated with atherosclerosis is endothelial 
dysfunction (ED), which has been shown to predict future cardiovascular events.  Chronic 
exercise is thought to improve endothelium-dependent vasodilation; however, few studies 
have evaluated the effects of acute exercise on vascular function (VF).  Moreover, studies 
evaluating ED following an exercise training program lack a standardized time frame in 
which to measure VF.  Although most studies require subjects to abstain from exercise for 
24 hours prior to any VF measure, no study to date has assessed VF longer than 24 hours 
after the cessation of exercise.  Additionally, no studies have compared VF responses in 
 vii
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obese and non-obese individuals following acute exercise.  Purpose:  Therefore, the 
purpose of this study was to evaluate VF, as determined by the assessment of forearm 
blood flow (FBF) and vascular reactivity (VR) before and up to 48 hours after a single 
bout of maximal exercise in obese and non-obese males.  Methods:  Twelve obese (37.0 ± 
1.1 kg/m2) and twelve non-obese (21.9 ± 0.3 kg/m2) males volunteered to participate.  FBF 
was assessed before and during reactive hyperemia (RH).  FBF measures were obtained 
prior to (PRE-E), immediately after (POST-E), and at 1 (POST-1), 2 (POST-2), 24 (POST-
24), and 48 (POST-48) hours after exercise.  Total excess flow, calculated as the difference 
between baseline FBF and FBF during RH, was used as an indicator of VR.  Blood 
samples were also obtained at each time point to evaluate the response of interleukin-6 (IL-
6) and tumor necrosis factor alpha (TNF-α), which are potential modifiers of VF.  Results: 
Baseline FBF and FBF during RH were significantly (P < 0.05) increased in both groups 
POST-E before returning to baseline values by POST-1.  VR was enhanced in both groups 
POST-E, although the magnitude of change was greater in non-obese males.  VR was 
significantly (P < 0.05) increased in non-obese males POST-E and was not significantly (P 
< 0.05) reduced until POST-48.  Concentrations of IL-6 and TNF-α were unchanged in 
response to exercise in non-obese and obese males.  Conclusions: An acute bout of 
maximal exercise significantly increased forearm endothelium-dependent vasodilation in 
non-obese and obese males.  Additionally, an increased reactive vasodilation was observed 
only in non-obese males following exercise.  These results also suggest that in non-obese 
males, measurements used to verify improvements in VF following exercise training 
should be employed after a minimum of 48 hours following physical activity.  
  
 
 
 
Introduction 
 
 
Atherosclerotic cardiovascular disease (CVD) is the leading cause of death in the 
United States, and has a 50% prevalence risk after the age of 40 years. (Lloyd-Jones et al., 
2004).  Atherosclerosis is distinguished by increased thickening of the arterial wall, 
accounting for approximately three-fourths of all CVD deaths (Rosamond et al., 2007).   
The clinical signs of CVD are final expressions of a disease process that has been 
progressing for decades.  One of the earliest sub-clinical stages in the atherosclerotic 
process is impairment of endothelium-dependent vasodilation, also known as endothelial 
dysfunction (ED) (Singhal, 2005).  ED can be detected prior to the development of 
atherosclerotic plaques in both coronary and peripheral vessels and has been implicated in 
the pathogenesis of diseases such as hypertension, diabetes, coronary artery disease, 
peripheral artery disease, chronic heart disease, and chronic renal failure (Endemann & 
Schiffrin, 2004).   
In healthy individuals, the quiescent state of the vascular system is maintained by 
vasoactive compounds produced from endothelial cells, most notably nitric oxide (NO).  
NO bioavailability is regulated by nitric oxide synthase (NOS), primarily located within 
caveolae of the cellular plasma membrane (Boo & Jo, 2003).  Shear stress, known as the 
dragging force of blood on the endothelial cell wall generated by flow, is one of the most 
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important mechanical regulators of endothelial NOS (eNOS) (Fisslthaler, Dimmeler, 
Hermann, Busse, & Fleming, 2000).  Both laminar and turbulent shear stresses induce 
phosphorylation of eNOS, although direct regulatory mechanisms of specific kinases and 
phosphorylases have yet to be elucidated.   
During endothelial cell activation an early biochemical marker is the loss of NO, 
initiating a chronic inflammatory response of the arterial walls.  The most notable 
disruption in vascular homeostasis is an imbalance in the release of vasoconstrictor and 
vasodilator compounds, initiating ED.  The bioavailability of this potent vasodilator, NO, 
is attenuated in many cardiovascular diseases such as hypertension, obesity, and 
atherosclerosis (M. Charakida et al., 2006). 
In 1988, researchers described the link between increased risk of cardiovascular 
mortality and observed risk factors such as obesity, hypertension, insulin resistance, and 
hypercholesterolemia as syndrome X, better known as the metabolic syndrome (MetS) (G. 
Reaven, 1988).  As a central causative component of MetS, obesity has been associated 
with several metabolic alterations (Hutley & Prins, 2005).  The World Health Organization 
defines obesity as a condition of excess body fat to the extent that health is impaired 
(Obesity: Preventing and managing the global epidemic. report of a WHO 
consultation.2000).  Body mass index (BMI, weight(kg)/height(m)2) has a close correlation 
to body fat and obesity-related diseases and is therefore often used to assess obesity (Y. 
Wang & Beydoun, 2007).  BMI cutoff points of 25 and 30 kg/m2 are used to define 
overweight and obesity, respectively.   
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In 1994, adipose tissue was recognized as a major site for secretion of protein 
signals with the discovery of leptin, helping to establish white adipose tissue (WAT) as an 
endocrine organ.  Obesity, which is directly related to an individual’s WAT, has recently 
been characterized as a state of chronic low-grade inflammation.  This review primarily 
focuses on two of the most frequently measured pro-inflammatory adipokines, TNF-α and 
IL-6, and their impact on endothelial function (EF).   
Although elevated levels of TNF-α play a role in numerous functions, a primary 
target is endothelial membrane receptors, which stimulate biological activity suggestive of 
ED (Ritchie et al., 2004).  TNF-α levels are inversely correlated to NO bioavailability (P. 
Wang, Ba, & Chaudry, 1994; Bhagat & Vallance, 1997).  IL-6, another adipokine often 
expressed as a pro-inflammatory marker, has recently received a great deal of attention, in 
particular with its release from skeletal muscle and its role as a myokine.  IL-6 is thought 
to negatively affect EF through an indirect pathway mediated by the stimulation of C-
reactive protein (CRP) released from the liver (Ritchie et al., 2004).  However, it has been 
proposed that the role of IL-6 is dependent upon its origin of secretion, such that release 
from adipose and skeletal muscle tissue may interact and oppose one another (Pedersen & 
Fischer, 2007b).  IL-6 secreted from contracting skeletal muscle results in the activation of 
anti-inflammatory pathways (Febbraio & Pedersen, 2005).   
The pathophysiology of ED includes an impairment of vasodilation initiated by a 
pro-inflammatory state.  Measurement of specific adipokines and other pro-inflammatory 
laboratory markers are considered a good complement to the direct assessment of EF.  Due 
to a strong association between ED and the initiating stages of atherosclerosis, as well as 
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clinical symptoms such as unstable angina and myocardial infarction (MI), the assessment 
of EF is crucial in targeting individuals with impaired vascular reactivity  (Vita & Keaney, 
2002).  Coronary ED has been shown to be an independent predictor of atherosclerotic 
disease progression and cardiovascular event rates in individuals with coronary artery 
disease (CAD), as well as those without CAD (Halcox et al., 2002; Schachinger, Britten, & 
Zeiher, 2000).  Since EF can be assessed years before any cardiovascular event, the need 
for a non-invasive measure of EF that can be used on multiple occasions during one’s 
lifespan to determine the presence and effectiveness of treatment of atherosclerosis is 
appealing.  Forearm blood flow (FBF), as assessed by venous occlusion strain-gauge 
plethysmography can provide non-invasive assessment of EF in peripheral vessels.  The 
relationship between ED in peripheral arteries is well established and peripheral ED has 
also been shown to predict future cardiovascular events (Anderson et al., 1995; Kitta et al., 
2009; Neunteufl et al., 1997; Shechter et al., 2007; Takase, Hamabe, Satomura, Akima, 
Uehata, Matsui, Ohsuzu, Ishihara, & Kurita, 2006; Tentolouris et al., 2004; Vita & 
Keaney, 2002; Yeboah, Crouse, Hsu, Burke, & Herrington, 2007). 
To date, there are no known studies that have evaluated the prognostic impact of 
FBF assessed by strain gauge plethysmography in predicting the long-term outcome of 
individuals with and without CAD.  However, strain gauge plethysmography has been 
used to demonstrate relationships among FBF and several cardiovascular disease risk 
factors (Ishibashi et al., 2006).  Chronic pro-inflammatory conditions, such as obesity can 
be significant in the initiation of atherosclerosis.  Due to ED being an early event in the 
progression of CVD, EF assessment could be of prognostic value since it reflects vascular 
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biology.  If ED is associated with the pathogenesis of CVD, it is often proposed that 
reversal of ED will reduce the risk for CVD.   
The beneficial effects of exercise on reducing risk for CVD are well known.  
Studies that have assessed the effects of exercise on ED have strengthened decisions to 
employ exercise training as an important therapy treatment for ED.  As previously 
described, increasing shear stress on endothelial cells stimulates secretion of NO leading to 
smooth muscle cell relaxation and subsequent vascular dilation.  Data suggest that regular 
exercise using a large muscle mass can induce adaptations in non-exercising limbs, which 
enhance EF (Kingwell, Sherrard, Jennings, & Dart, 1997).  Important findings such as this 
justify the evaluation of FBF with common aerobic exercise modalities such as cycling and 
walking.   
Many studies have shown an exercise training effect on EF with subjects who were 
at higher risk for CVD (Watts, Beye, Siafarikas, O'Driscoll et al., 2004; Woo et al., 2004; 
Hamdy et al., 2003; Schjerve et al., 2008; Higashi et al., 1999; Maiorana et al., 2001; 
Walsh, Yong et al., 2003).  Interestingly, Green et al. (2003) investigated whether EF 
improvements observed with exercise resulted from short term repetitive exercise bouts or 
exercise associated improvements in CVD risk factor profiles (Green et al., 2003).  The 
study suggested that these changes in EF are not exclusively related to the effect that 
exercise has on CVD risk factors, further demonstrating the impact exercise training has on 
the vascular system, with its frequent, periodic increase in shear stress.               
Although most exercise training studies have evaluated subjects with an increased 
risk for CVD disease, a limited number of studies have evaluated the effect of exercise 
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training on EF in healthy subjects (Clarkson et al., 1999; Goto et al., 2003; Higashi et al., 
1999; Rakobowchuk et al., 2008; Bergholm et al., 1999; Goto et al., 2003; Rakobowchuk 
et al., 2005).  Moreover, these studies are not in complete agreement that EF is enhanced 
following exercise training in healthy individuals.  Currently, studies appear to support an 
improvement in EF in healthy individuals following moderate-intensity aerobic exercise 
training.  These positive changes in EF with moderate-intensity training are not well 
supported in high-intensity aerobic exercise training or strength exercise training models.   
While most studies examine EF following exercise training, EF following acute 
exercise has not been extensively researched.  Only a few studies have evaluated the effect 
of a single bout of exercise on EF in healthy individuals (Baynard, Miller, & Fernhall, 
2003; Bousquet-Santos, Soares, & Nobrega, 2005; Rognmo et al., 2008).  Although all of 
the studies demonstrated an increased EF measure immediately post-exercise, Bousquet-
Santos et al. suggested a return of EF measures to baseline levels within 2 hours of 
exercise (Bousquet-Santos, Soares, & Nobrega, 2005).  Previous studies have presented 
important findings in further understanding the effects of acute exercise on EF.  However, 
an extensive review of literature has produced no study in which the extended time-course 
for EF following a single bout of maximal exercise is shown, especially in obese 
individuals.  This is of primary importance considering a previous study has demonstrated 
an exercise-induced effect up to 24 hours of inflammatory biomarkers that may have an 
effect on the EF (Louis, Raue, Yang, Jemiolo, & Trappe, 2007).  The impact of 
inflammatory markers post-exercise could be crucial in assessing EF post-exercise, where 
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there does not appear to be a standardized optimal time before EF is assessed following a 
training program’s last exercise bout.   
The critical effect of endothelial wall activation and its associated role in initiating 
atherosclerosis warrants further research of the mediating receptors and circulating agents 
that allow for the control of vascular homeostasis.  Assessing EF and the biomarkers 
associated with its control is vital in understanding interventions that may help not only 
slow the progression of CVD but negate specific CVD risk factors.  The underlying 
mechanisms that control EF changes following exercise training have received a large 
amount of attention and continue to be evaluated.  PA has been shown as an important 
mediator for improving EF through the generation of shear stress.  This study aims to 
investigate an extended time course of acute exercise-induced adaptation on EF.  The time 
course of exercise induced adaptations on EF has been evaluated in only a few studies 
giving rise to the need for a similar study in healthy and obese subjects.  Exercise training 
study results are inconclusive as to whether the exercise interventions improve EF or 
whether improvements in EF are simply a reflection of the alterations from the last 
exercise bout performed.  Findings may help establish an optimal time point to assess EF 
following an exercise training program and also allow researchers to further understand the 
impact an acute exercise bout can have on regulating the vasodilatory capacity of the 
arterial wall. 
 
  
 
Review of Literature 
 
 
 Atherosclerotic cardiovascular disease (CVD) is the leading cause of death 
in the United States, and has a 50% prevalence risk after the age of 40 years. (Lloyd-Jones 
et al., 2004).  Atherosclerosis is distinguished by increased thickening of the arterial wall, 
accounting for approximately three-fourths of all CVD deaths (Rosamond et al., 2007).   
Pathological changes in arteries that occur in children and young adults prior to the onset 
of adult clinical symptoms have indicated a long preclinical phase of atherosclerosis.  The 
clinical signs of CVD are final expressions of a disease process that has been progressing 
for decades.   It is now known that early life events have a lasting impact on the 
development of atherosclerosis and risk for CVD (Napoli et al., 1999; Singhal, 2005; 
Skilton & Celermajer, 2006).   
One of the earliest subclinical stages in the atherosclerotic process is impairment of 
endothelium-dependent vasodilation, also known as endothelial dysfunction (ED) (Singhal, 
2005).  ED can be detected prior to the development of atherosclerotic plaques in both 
coronary and peripheral vessels and has been implicated in the pathogenesis of diseases 
such as hypertension, diabetes, coronary artery disease, peripheral artery disease, chronic 
heart disease, and chronic renal failure (Endemann & Schiffrin, 2004).  Vascular 
homeostasis is regulated by the endothelium, a single layered paracrine organ lining the 
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blood vessels with a pleiotropic role consisting of modulating vascular tone, cellular 
adhesion, thromboresistance, smooth muscle cell proliferation, and vessel wall 
inflammation (Deanfield, Halcox, & Rabelink, 2007).  The earliest studies on the 
significance of endothelial cells investigated the production and release of compounds 
effecting vascular tone.  In 1980, experiments of Furchgott and Zawadzki were the first to 
demonstrate the action of acetylcholine on endothelial cells, which released a substance 
targeting smooth muscle and initiated relaxation (Furchgott & Zawadzki, 1980).  The 
biological activity of this endothelial-derived relaxing factor (EDRF) was later compared 
to nitric oxide (NO), where the EDRF and NO relaxation of bioassay tissues were shown 
to be significantly similar (Palmer, Ferrige, & Moncada, 1987).  It was also suggested that 
both EDRF and NO were inhibited by oxyhemoglobin and stimulated by superoxide 
dismutase (SOD), thus providing evidential support in proposing that EDRF and NO were 
the same (Ignarro, Buga, Wood, Byrns, & Chaudhuri, 1987; Palmer et al., 1987). 
MECHANISMS REGULATING ENDOTHELIAL FUNCTION 
In healthy individuals, the quiescent state of the vascular system is maintained by 
vasoactive compounds produced from endothelial cells, most notably NO.  NO 
bioavailability is regulated by nitric oxide synthase (NOS), primarily located within 
caveolae of the cellular plasma membrane (Boo & Jo, 2003).  When activated, NOS 
mobilizes, converting molecular oxygen and L-arginine to NO and L-citrulline.  Three 
tissue specific NOS isoforms (neuronal NOS (nNOS), inducible NOS (iNOS), and 
endothelial NOS (eNOS)) have been identified.  NO derived from eNOS is essential in 
regulating cardiovascular homeostasis (M. Charakida, Deanfield, & Halcox, 2006; 
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Forstermann & Munzel, 2006).    Endothelium-derived NO diffuses into adjacent smooth 
muscle cells activating soluble guanylyl cyclase (sGC), which synthesizes cyclic guanosine 
monophosphate (cGMP) from guanosine triphosphate (GTP) (M. Charakida et al., 2006; 
Murad, 2006).  cGMP is an intracellular second messenger with many roles, one of which 
includes the activation of intracellular protein kinases.  Activated protein kinases decrease 
the concentration of cytosolic calcium, which leads to the dephosphorylation of smooth 
muscle myosin light chain, thus vascular relaxation (Murad, 2006).   
There are many eNOS agonists, which include humoral, mechanical, metabolic, 
and pharmacological stimuli.  Initially, the proposed stimulation of eNOS consisted of a 
simple calcium (Ca2+) dependent model, in which activation of eNOS was controlled by 
Ca2+/calmodulin (CaM) binding (Fleming & Busse, 2003; Moncada & Higgs, 1993; 
Mount, Kemp, & Power, 2007).  However, it has since been shown that a wide variety of 
eNOS stimuli regulate NO production through more complex pathways including protein-
protein interactions and site-specific phosphorylation involving kinases and 
phosphorylases (Boo et al., 2002; Fleming & Busse, 2003; Mount et al., 2007).  Shear 
stress, known as the dragging force of blood on the endothelial cell wall generated by flow, 
is one of the most important mechanical regulators of eNOS (Fisslthaler, Dimmeler, 
Hermann, Busse, & Fleming, 2000).  Both laminar and turbulent shear stresses induce 
phosphorylation of eNOS, although direct regulatory mechanisms of specific kinases and 
phosphorylases have yet to be elucidated.   
In brief, shear stress activates guanine nucleotide binding (G) protein’s-coupled 
transmembrane receptor, which induces activation of phosphoinositide 3-kinase (PI3K). 
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PI3K indirectly activates 3-phosphoinositide-dependent protein kinase 1 and 2 (PDK1 and 
PDK2, respectively) (Boo et al., 2002; Sessa, 2004).  PDK1 and PDK2 phosphorylate 
protein kinases responsible for phosphorylation of eNOS at specific amino acid sites.  Thus 
far, five eNOS phosphorylation sites have been identified, the most notable recognized as 
serine 1177 (Ser1177) (Boo & Jo, 2003; Mount et al., 2007).  Other phosphorylation sites 
stimulated by shear stress include serine 114 (Ser114) and serine 633 (Ser633) (Mount et al., 
2007). 
Although NO is widely known for its vasodilatory effect, there are other actions 
elicited by NO production that are beneficial such as regulation of smooth muscle cell 
proliferation and inhibition of vascular platelet adhesion (de Graaf et al., 1992; Freedman 
et al., 1997; Ignarro et al., 2001; Michelson et al., 1996; Stein, Fabry, Murphy, & Hart, 
1995).  Along with impaired endothelium-dependent vasodilation, increased vascular 
smooth muscle cell proliferation is a familiar characteristic of atherosclerosis.  Growth 
factors necessary for cellular reproduction include polyamines, such as putrescine, 
spermidine, and spermine.  NO has been shown to inhibit ornithine decarboxylase, an 
enzyme responsible for converting the amino acid ornithine to putrescine (Ignarro et al., 
2001).  Research has also suggested that NO prevents thrombus formation through 
inhibition of platelet aggregation (de Graaf et al., 1992; Freedman et al., 1997; Michelson 
et al., 1996).  NO production has also been shown to inhibit surface platelet P selectin 
(Freedman et al., 1997; Michelson et al., 1996).  P selectin, a cell adhesion molecule, is 
secreted from activated platelets and is responsible for increasing platelet adhesion to 
monocytes and stimulating tissue factor (Freedman et al., 1997).  Monocytes and tissue 
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factor can both exacerbate atherosclerosis by increasing arterial plaque and coagulation of 
blood, respectively.     
During endothelial cell activation an early biochemical marker is the loss of NO, 
initiating a chronic inflammatory response of the arterial walls.  The most notable 
disruption in vascular homeostasis is an imbalance in the release of vasoconstrictor and 
vasodilator compounds, initiating ED.  The bioavailability of this potent vasodilator, NO, 
is attenuated in many cardiovascular diseases such as hypertension, obesity, and 
atherosclerosis (M. Charakida et al., 2006). 
This review will focus primarily on adipokines and the impact they have in 
regulating NO bioavailability and thus vascular reactivity.  Although reactive oxygen 
species (ROS) are not discussed in this review, they do exert a significant influence on NO 
bioavailability and future research in this area will be critical in helping clarify the 
relationship between NO and endothelial function (EF).   
METABOLIC SYNDROME AND OBESITY 
In 1988, researchers described the link between increased risk of cardiovascular 
mortality and observed risk factors such as obesity, hypertension, insulin resistance, and 
hypercholesterolemia as syndrome X, better known as the metabolic syndrome (MetS) (G. 
Reaven, 1988).  Individuals diagnosed with MetS were identified for an early intervention 
in an attempt to decrease the development of type 2 diabetes or CVD (G. M. Reaven, 
2005).  Today, MetS is identified as having three of five criteria (abdominal obesity, 
impaired fasting glucose, high triglyceride and low HDL-cholesterol concentrations, and 
increased blood pressure) determined by the Adult Treatment Panel III of the National 
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Cholesterol Education Program (G. M. Reaven, 2005).  Current data used for extrapolative 
analysis project that nearly 40% of the world’s population will be affected by MetS by 
2020 (New developments in metabolic syndrome. proceedings of the 1st conference of the 
paul hamel institute. 7-8 june 2004, monaco.2005).  As a central causative component of 
MetS, obesity has been associated with several metabolic alterations (Hutley & Prins, 
2005).  While obesity is the primary focus of this review, each component of MetS has the 
potential to independently affect EF.  
The World Health Organization defines obesity as a condition of excess body fat to 
the extent that health is impaired (Obesity: Preventing and managing the global epidemic. 
report of a WHO consultation.2000).  Body mass index (BMI, weight(kg)/height(m)2) has 
a close correlation to body fat and obesity-related diseases and is therefore often used to 
assess obesity (Y. Wang & Beydoun, 2007).  BMI cutoff points of 25 and 30 kg/m2 are 
used to define overweight and obesity, respectively.  The prevalence of obesity has more 
than doubled in the last thirty years, accounting for approximately 32.4% of obese adults in 
the United States (Y. Wang & Beydoun, 2007).  Using linear regression models, Wang and 
Beydoun suggested that by 2015 the prevalence of obesity in adults and adolescents will 
reach 40.8 and 22.7 percent, respectively (Y. Wang & Beydoun, 2007).   
Until recently, white adipose tissue’s (WAT) primary role was thought to be energy 
storage.  In 1994, adipose tissue was recognized as a major site for secretion of protein 
signals with the discovery of leptin, helping to establish WAT as an endocrine organ.  Over 
50 protein signals are now known to be secreted from WAT and various functional roles 
have led researchers to collectively name them ‘adipokines’ (Trayhurn & Wood, 2004).  
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The pleiotropic role of adipokines has helped establish WAT’s elaborate communication 
system with other tissues and organs.  Obesity, which is directly related to an individual’s 
WAT, has recently been characterized as a state of chronic low-grade inflammation.  
Several mechanisms have been proposed to help explain this phenomenon.  These include: 
a) the elevation of obesity-related adipokines with proinflammatory functional properties 
(Fantuzzi, 2005; Lau, Dhillon, Yan, Szmitko, & Verma, 2005; Ritchie, Ewart, Perry, 
Connell, & Salt, 2004; Wisse, 2004), b) the reduced anti-inflammatory function of insulin 
as a result of the increased obesity related adipokines (Bruun, Verdich, Toubro, Astrup, & 
Richelsen, 2003; Caballero, 2003; Fantuzzi, 2005; Fasshauer & Paschke, 2003; Lau et al., 
2005; Ritchie et al., 2004; Wisse, 2004), c) the increased production of free radicals as a 
result of oxidative stress (Ritchie et al., 2004), and d) the hypoxic condition of adipocytes 
as WAT increases disproportional to its vascular network (Trayhurn & Wood, 2004). 
ADIPOKINES AND NITRIC OXIDE REGULATION 
During the last 15 years, many pro-inflammatory adipokines have been discovered 
including interleukin (IL) 1βeta, IL-6, IL-8, IL-10, tumor necrosis factor-α (TNF-α), 
vascular endothelial growth factor (VEGF), and leptin (Trayhurn & Wood, 2005).  This 
review will primarily focus on two of the most frequently measured pro-inflammatory 
adipokines, TNF-α and IL-6, and their impact on EF.   
TNF-α is biologically active as a 17 kDa protein involved in the escalation of a pro-
inflammatory state (Ronti, Lupattelli, & Mannarino, 2006).  BMI and percent body fat are 
both positively correlated to plasma TNF-α (Ritchie et al., 2004).  Although elevated levels 
of TNF-α play a role in numerous functions, a primary target is endothelial membrane 
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receptors, which stimulate biological activity suggestive of ED (Ritchie et al., 2004).  
TNF-α levels are inversely correlated to NO bioavailability.  Wang et al. revealed that 2 
hours of in vivo administered TNF-α in male Sprague-Dawley rats significantly decreased 
NO synthesis and release, leading to impairment of endothelium-dependent vasodilation 
for up to 80 minutes (P. Wang, Ba, & Chaudry, 1994).  Bhagat et al. infused TNF-α for 
one hour in healthy males and females 19 – 40 years of age (Bhagat & Vallance, 1997).  
The researchers suggested that endothelium-dependent vasodilation was attenuated up to 
six hours.  However, in this study, it is important to note that prior to six hours only one 
post TNF-α measurement was taken, which was obtained at one hour.  Therefore, it is not 
known if the return to baseline endothelium-dependent vasodilation occurred prior to six 
hours.  These findings suggest that TNF-α effects endothelium-dependent vasodilation in a 
time-dependent manner.  Possible explanations for the depression in endothelium-
dependent vasodilation with TNF-α include inhibition of receptor-mediated release of NO 
from endothelial cells, degradation of NOS mRNA, and increases in endothelin (ET) 
(Bhagat & Vallance, 1997; Ritchie et al., 2004; P. Wang et al., 1994).  TNF-α has also 
been shown to stimulate adhesion molecules such as intracellular cell-adhesion molecule-1 
(ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) (Ritchie et al., 2004; Ronti et 
al., 2006).  These adhesion molecules enhance monocyte attachment to the endothelial wall 
(Ronti et al., 2006).  The monocytes then migrate to the subendothelial space where they 
become foam cells.  Foam cells contain oxidized low density lipoprotein (LDL) and can 
lead to the development and progression of atherosclerosis.   
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ET is released from endothelial cells and binds to two receptor subtypes, ETA and 
ETB, located on smooth muscle cells, adjacent to the endothelial cells (Bohm & Pernow, 
2007).  The receptors are coupled to a G-protein, which stimulates the production of 
intracellular inositol triphosphate (IP3).  Subsequently, Ca++ is released from the 
sarcoplasmic reticulum, leading to phosphorylation of smooth muscle myosin light chain, 
thus vascular constriction.  ETB receptors can also be found on endothelial cells and when 
stimulated result in the production of cGMP and secretion of NO, leading to vascular 
relaxation (Bohm & Pernow, 2007).  G-proteins can have different functional roles 
depending on the stimulation of various subunits.  G-proteins are heterodimers made of α, 
β, and γ subunits, each with several isoforms (Neer, 1994; Oldham & Hamm, 2006).  The 
various G-protein types give rise to a wide range of specific cellular responses from 
external stimuli.  It has been suggested that the Gαs and Gαq families are specific in 
production of cGMP and IP3, respectively (Neer, 1994; Oldham & Hamm, 2006).  In a 
healthy vessel, the net balance effect of ETA and ETB activation is vascular relaxation.  In a 
disease condition such as ED, the sensitivity of ET is much more pronounced, resulting in 
an upregulation of the vasoconstrictor ETB receptor located on smooth muscle cells (Bohm 
& Pernow, 2007).  ET has also been shown to stimulate the production of both TNF-α and 
IL-6, which in turn exacerbate the production of ET.   
IL-6, another adipokine often expressed as a pro-inflammatory marker, has recently 
received a great deal of attention, in particular with its release from skeletal muscle and its 
role as a myokine.  Although IL-6 is positively correlated with obesity and significantly 
decreases with weight loss, secretion from adipose tissue only accounts for ~10% of total 
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concentration (Ronti et al., 2006).  Plasma IL-6 concentration is positively correlated with 
the development of CVD (Avogaro & de Kreutzenberg, 2005).  Although IL-6 is thought 
to negatively affect EF, it has been suggested that this occurs primarily through an indirect 
pathway mediated by the stimulation of C-reactive protein (CRP) released from the liver 
(Ritchie et al., 2004).  Recent evidence has shown IL-6 to be the only cytokine secreted 
from skeletal muscle and be released into circulation following exercise (Pedersen & 
Fischer, 2007a).  IL-6 had previously been recognized as a pro-inflammatory cytokine that 
contributed to insulin resistance.  Mechanistically, an exercise-induced increase in IL-6 
failed to explain the increase in post-exercise insulin action.  Researchers then began to 
suggest that the pro-inflammatory association with IL-6 was primarily due to positive 
correlations in cohort studies, animal studies, and in vitro studies that had 
supraphysiological concentrations, none of which best represent in vivo human 
physiological studies (Pedersen & Fischer, 2007b).  It is important to distinguish between 
acute versus chronic secretion of IL-6 and different functional properties that may be 
associated with each.  It has been proposed that the role of IL-6 is dependent upon its 
origin of secretion, such that release from adipose and skeletal muscle tissue may interact 
and oppose one another (Pedersen & Fischer, 2007b).  IL-6 secreted from contracting 
skeletal muscle results in the activation of anti-inflammatory pathways (Febbraio & 
Pedersen, 2005).  Muscle derived IL-6 is linked to an increase in well-known anti-
inflammatory cytokines (e.g. interleukin 10 (IL-10) and interleukin 1 receptor antagonist 
(IL-1ra)) as well as inhibition of TNF-α.  Whereas, IL-6 released from adipose tissue is 
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associated with an increase in the pro-inflammatory marker CRP (Avogaro & de 
Kreutzenberg, 2005; Pedersen & Fischer, 2007b; Ritchie et al., 2004).   
CRP is thought to be one of the strongest independent predictors of CHD and is 
significantly correlated to body fat, MetS, and type 2 diabetes (Lau et al., 2005; Verma et 
al., 2002).  CRP directly alters EF through augmented expression of adhesion molecules 
VCAM-1 and ICAM-1, as well as increasing secretion of ET (Lau et al., 2005; Pasceri, 
Willerson, & Yeh, 2000).  CRP further exacerbates its production through a positive 
feedback mechanism in which it increases expression of IL-6.  CRP has also been shown 
to down regulate eNOS mRNA, attenuating NO production (Verma et al., 2002).  This 
impact is mediated through a reduction in eNOS mRNA half-life, which has been 
suggested to significantly decrease from 24 to 14 hours in plate grown endothelial cells 
treated with CRP. 
ASSESSMENT OF ENDOTHELIAL FUNCTION 
As previously discussed, the pathophysiology of ED includes an impairment of 
vasodilation initiated by a pro-inflammatory state.  Measurement of specific adipokines, 
cellular adhesion molecules, and other pro-inflammatory laboratory markers are considered 
a good complement to the direct assessment of EF.  Currently, there are three primary 
methods of EF assessment.  These include coronary angiography, high-resolution vascular 
ultrasonography, and venous occlusion strain-gauge plethysmography.   
Coronary Angiography 
Direct measurement through coronary angiography is an invasive in situ test that 
poses high risk for cardiovascular events such as myocardial infarction or stroke 
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(Kasprzak, Klosinska, & Drozdz, 2006).  Researchers infuse acetylcholine into the 
coronary artery before attempting to detect diameter change.  Acetylcholine increases the 
release of NO by activating muscarinic receptors located on the endothelial membrane.  An 
increased risk for atherosclerosis is often designated in areas where vasodilation does not 
occur (Kasprzak et al., 2006).   
High Resolution Vascular Ultrasonography 
ED can also occur in peripheral conduit arteries, which allows for the non-invasive 
in vivo assessment of a more accessible vessel, such as the brachial artery.  It is presumed 
that ED through brachial artery assessment is closely related to ED in coronary arteries 
(Vita & Keaney, 2002).  Flow-mediated dilation (FMD) of the brachial artery is measured 
through high resolution vascular ultrasonography and is the most commonly used test for 
assessing EF.  Briefly, the brachial artery diameter in the upper arm is measured from 
brightness (B) mode ultrasound images (Patel & Celermajer, 2006; Watts, Beye, 
Siafarikas, Davis et al., 2004).  Ultrasound transducers must be greater than 7 MHz in 
order to obtain optimal resolution (Patel & Celermajer, 2006).  Baseline measurements, 
which include diameter and blood flow velocity, are recorded for one minute.  The FMD is 
induced by endothelial cells detecting changes in sheer stress during increasing turbulent 
flow following brief ischemia.  Ischemia is caused by rapid inflation of a 
sphygmomanometer cuff wrapped around the forearm.  The cuff is inflated to 250 – 300 
mmHg for at least 4.5 minutes (Kasprzak et al., 2006; Patel & Celermajer, 2006; Watts, 
Beye, Siafarikas, O'Driscoll et al., 2004).  Following cuff deflation, recordings are again 
measured for 1 minute.  The percent change in brachial artery diameter from baseline to 
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45-60 seconds after deflation is recorded as FMD (Williams et al., 2005).  After measuring 
FMD following brief ischemia, FMD is measured following sublingual administration of 
nitroglycerin (NTG).  NTG causes vascular relaxation in an endothelium-independent 
manner and is often used as a control against the ischemic condition.  At baseline, the ideal 
vessel diameter is 2.5 – 5 mm.  A larger vessel may not be associated with significant 
increases in vasodilation, even when normal EF exists (Patel & Celermajer, 2006).  It is 
often hard to obtain an accurate image in a vessel smaller than 2.5 mm.  In adult subjects, 
vessel size is not often an issue, however, in children the artery of choice becomes the 
femoral artery (Patel & Celermajer, 2006).  Due to differences in FMD with different size 
vessels, it is recommended that all values be reported as an absolute change in diameter 
(Kasprzak et al., 2006).  Variations in FMD also exist between fasting and post-prandial 
conditions, therefore, it is important to test individuals in a fasting state.   
FMD values are different among diverse populations.  Individual’s with known 
CHD, Type 2 diabetes, and healthy volunteers have FMD values that vary between -1.3 to 
14%, 0.75 to 12%, and 0.2 to 21%, respectively (Berry, Skyrme-Jones, & Meredith, 2000; 
Kasprzak et al., 2006).  These variations in baseline FMD values make it difficult in 
defining normal ranges.  Researchers attribute these differences to arterial occlusion times, 
positioning of the occlusion cuff, and time point of vessel measurement following cuff 
deflation (Berry et al., 2000).  Various studies have used an occlusion cuff on the upper 
arm rather than the forearm.  When this occurs, brachial artery diameter measurements 
occur in the forearm rather than the upper arm.  If an upper arm cuff is used to assess FMD 
then occlusion time must last for at least 5 minutes (Berry et al., 2000).  Researchers have 
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suggested that brachial artery FMD was significantly greater when upper arm occlusion 
was used compared to forearm occlusion (Agewall et al., 2001; Berry et al., 2000; Peretz et 
al., 2007).  Berry et al. also suggested that peak FMD occurred at different times 
depending on cuff placement (Berry et al., 2000).  FMD peaked at 71 seconds with upper 
arm occlusion compared to 49 seconds with forearm occlusion.  Participants in both upper 
and lower arm occlusion groups were separated based on their time to peak FMD.  
Although most subjects with forearm occlusion reached peak FMD within 60 seconds, 
there were still 6% of participants who did not see a peak FMD until after 60 seconds.  Of 
those participants who had their upper arm occluded to assess FMD, 69% of the subjects 
experienced peak FMD after 60 seconds.  These results have been shown in a more recent 
study and give rise to concern for variations found in studies that use the first 60 seconds to 
assess changes in FMD as well as comparing results using different arm occlusion sites 
(Peretz et al., 2007).  While the brachial artery is often used to measure changes in FMD, 
the radial artery can also be measured following forearm occlusion.  Agewall et al. 
compared FMD changes in the brachial and radial arteries following occlusion of both the 
upper arm and forearm (Agewall et al., 2001).  FMD was greatest in the radial artery, 
regardless of where cuff occlusion occurred. 
Venous Occlusion Strain-Gauge Plethysmography 
Another non-invasive in vivo tool used to assess EF that is practical and relatively 
low-cost is venous occlusion strain-gauge plethysmography.  In many laboratories, it is the 
preferred method in assessing EF because it does not require a radiological technologist as 
does the vascular ultrasonography.   Strain-gauge plethysmography works similar to high 
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resolution vascular ultrasonography in measuring post-occlusive reactive hyperemia.  
Following an overnight fast, subjects are positioned in a supine position and acclimatize 
for at least thirty minutes (Thijssen, Bleeker, Smits, & Hopman, 2005).  The arm is placed 
approximately 5 cm above the level of the heart and a sphygmomanometer cuff is placed 
around the upper arm.  The cuff is attached to a rapid cuff inflator.  A mercury-in-silastic 
strain gauge is placed on the largest portion of the forearm.  A smaller cuff is placed 
around the wrist and inflated to super-systolic pressures prior to any measurement in 
attempt to minimize the contribution of hand blood flow, which has a different control 
function compared to forearm blood flow (FBF) (Leslie et al., 2004).  This allows forearm 
volume to increase in conjunction with an increase in FBF.  The increased forearm volume 
can be detected through increases in forearm circumference measured by changes in the 
mercury-in-silastic strain gauge (Leslie et al., 2004).  A baseline measurement is recorded 
as the upper arm cuff is inflated above venous pressure but below arterial pressure.  This 
allows venous outflow to be obstructed while arterial inflow remains the same.  The upper 
arm cuff is inflated for ten seconds and deflated for five seconds while FBF is measured.  
Averages of five measurements are taken.  Peak FBF is measured following post-occlusive 
hyperemia induced by inflating the upper cuff to super-systolic pressure for at least 5 
minutes before FBF measurement is taken. 
Technical considerations that should be considered for using venous occlusion 
strain-gauge plethysmography include appropriate venous occlusion pressure and duration 
of venous occlusion.  It has been reported that several studies apply a standard venous 
occlusion of 50 mmHg while others employ a value dependent on subject’s diastolic 
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pressure (Alomari et al., 2004).  Researchers suggested that venous occlusion of 7, 14, 21, 
28, and 35 mmHg below diastolic pressure had a stepwise decrease in venous capacitance, 
respectively (Alomari et al., 2004).  The study also compared venous outflow with the 
same pressure values and illustrated a stepwise decrease as occlusion pressure decreased, 
suggesting a strong positive relationship between venous capacitance and venous outflow.  
Forearm inflow was not altered, providing a significant role for occlusion pressure as 
forearm circumference is related to venous outflow.  Alomari et al. also showed that peak 
forearm blood inflow and venous outflow were both significantly correlated to 
cardiovascular fitness (Alomari et al., 2004).  The positive relationship between peak 
oxygen consumption (VO2peak) and both arterial inflow and venous outflow, clearly 
demonstrate the ability for arteries and veins to deliver nutrients and remove waste 
metabolites from blood during increasing levels of muscle contraction, potentially reducing 
muscular fatigue. 
CLINICAL SIGNIFICANCE OF ENDOTHELIAL FUNCTION 
Due to a strong association between ED and the initiating stages of atherosclerosis, 
as well as clinical symptoms such as unstable angina and myocardial infarction (MI), the 
assessment of EF is crucial in targeting individuals with impaired vascular reactivity  (Vita 
& Keaney, 2002).  Coronary ED has been shown to be an independent predictor of 
atherosclerotic disease progression and cardiovascular event rates in individuals with 
coronary artery disease (CAD), as well as those without CAD (Halcox et al., 2002; 
Schachinger, Britten, & Zeiher, 2000).  Shachinger et al. evaluated the long term outcome 
(6.7±3.2 years) of individuals who were undergoing routine evaluation of chest pain or 
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percutaneous transluminal coronary angioplasty for single vessel disease (Schachinger et 
al., 2000).  FMD measured by coronary angiography demonstrated a significant inverse 
relationship between the incidence of cardiovascular events and both flow-dependent and 
NTG-induced vasodilation.  To determine if the incidence of cardiovascular events was 
inversely related to endothelial cell or smooth muscle cell function, the investigators 
normalized flow-dependent vasodilation to NTG-induced vasodilation.  After 
normalization of NTG-induced vasodilation, flow-dependent vasodilation significantly 
predicted cardiovascular events, suggesting that impaired coronary vasodilation was 
directly related to endothelial cell function (Schachinger et al., 2000).  Halcox et al. 
examined the change in coronary vascular resistance (CVR) during the arterial infusion of 
the endothelial-dependent vasodilator, acetylcholine (ACH), in patients with angiographic 
evidence of irregularity, as well as individuals with angiographically smooth coronary 
arteries (Halcox et al., 2002).  The investigators demonstrated that individuals with the 
greatest change in CVR were more likely to have a cardiovascular event-free survival 
(46±3 months), independent of the presence of CAD.   
Although the relationship between CAD and coronary ED is well supported, the 
invasive measure is not feasible in healthy individuals or even those with only suspected 
coronary ED.  Since EF can be assessed years before any cardiovascular event, the need 
for a non-invasive measure of EF that can be used on multiple occasions during one’s 
lifespan to determine the presence and effectiveness of treatment of atherosclerosis is 
appealing.  FMD and FBF, as assessed by high resolution vascular ultrasonography and 
venous occlusion strain-gauge plethysmography, respectively, can provide non-invasive 
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assessment of EF in peripheral vessels.  As previously mentioned, the relationship between 
ED in human coronary and peripheral arteries is well established and peripheral ED has 
also been shown to predict future cardiovascular events (Anderson et al., 1995; Kitta et al., 
2009; Neunteufl et al., 1997; Shechter et al., 2007; Takase, Hamabe, Satomura, Akima, 
Uehata, Matsui, Ohsuzu, Ishihara, & Kurita, 2006; Tentolouris et al., 2004; Vita & 
Keaney, 2002; Yeboah, Crouse, Hsu, Burke, & Herrington, 2007). 
Anderson et al. were the first to demonstrate a relationship between percent 
diameter changes in two different vascular beds of the same individual (Anderson et al., 
1995).  The investigators demonstrated a significant positive relationship with brachial and 
coronary vasodilation.  The relationship was shown in patients with and without CAD, 
suggesting that ED is not restricted to vessels with evident atherosclerosis and may be an 
early “functional expression” of the atherosclerotic process (Anderson et al., 1995).  Other 
studies supported FMD of the brachial artery as a useful non-invasive tool to measure EF 
and provided evidence that that ED may be an early “functional expression” of 
atherosclerosis (Kitta et al., 2009; Neunteufl et al., 1997; Takase, Hamabe, Satomura, 
Akima, Uehata, Matsui, Ohsuzu, Ishihara, & Kurita, 2006; Yeboah, Crouse, Hsu, Burke, & 
Herrington, 2007).  Neunteufl et al. reported data from a multiple regression stepwise 
analysis suggesting that brachial artery FMD had a significant inverse correlation with the 
severity of CAD (Neunteufl et al., 1997).  Subjects from the study with CAD had 
significantly less FMD than non-CAD subjects.  NTG induced vasodilation was not 
significantly different between CAD and non-CAD subjects, suggesting that impairment in 
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vascular relaxation in CAD subjects was directly related to endothelial cell function as 
opposed to smooth muscle cell activity (Neunteufl et al., 1997).   
More recently, Takase et al., suggested that the brachial artery’s response to ACH 
was significantly correlated to the response of the coronary artery to ACH in individuals 
with low to moderate cardiovascular risk factors and only slight suspicion of CAD 
(Takase, Hamabe, Satomura, Akima, Uehata, Matsui, Ohsuzu, Ishihara, & Kurita, 2006).  
The investigators followed these same individuals for 53 ± 17 months and demonstrated 
that the peripheral vessel’s dilatory capacity was useful in predicting the incident of long-
term cardiovascular events.  Employing the brachial artery’s dilation capacity as a means 
to predict cardiovascular events has been well documented in other studies (Kitta et al., 
2009; Shechter et al., 2007; Yeboah, Crouse, Hsu, Burke, & Herrington, 2007).   
Shechter et al. assessed EF between healthy and stable CVD subjects (Shechter et 
al., 2007).  Brachial artery FMD was significantly lower in CVD subjects compared to 
healthy controls and there was no significant difference in NTG-induced dilation between 
the two groups.  All subjects were divided into groups based on cardiovascular risk factors 
such as gender, hypertension, hyperlipidemia, smoking history, diabetes mellitus and 
family history.  FMD was significantly lower in males compared to females and non-
significantly lower in diabetic compared to non-diabetic subjects (Shechter et al., 2007).  
This study reported no significant correlation between FMD and hypertension, 
hyperlipidemia, smoking and family history.  When FMD was analyzed against an 
individual’s number of CVD risk factors, there was a significant inverse relationship.  
Healthy individual’s baseline brachial artery was significantly larger compared to the CVD 
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patients.  In addition, the baseline brachial artery diameter and FMD had a significant 
inverse correlation.  The investigators speculated that large diameter arteries are unable to 
reach maximal dilation, further illustrating the impaired vascular function of the CVD 
patients (Shechter et al., 2007).  Of note, both healthy and CVD subjects had mean 
baseline brachial artery diameters greater than 5 mm, which is larger than the 
recommended size when assessing FMD.  Shechter et al. followed up all subjects 15 ± 2 
months for CVD endpoints (e.g. all-cause mortality, MI, hospitalization for heart failure or 
angina pectoris, cerebrovascular accident, CABG and percutaneous coronary interventions) 
(Shechter et al., 2007).  CVD endpoints were significantly more frequent in subjects who 
had less than 6% brachial artery FMD change in response to reactive hyperemia. 
Yeboah et al. were the first to evaluate brachial artery FMD as a predictor of 
cardiovascular events in older adults aged 72 to 98 years (Yeboah, Crouse, Hsu, Burke, & 
Herrington, 2007).  Study participants were contacted biannually during a five year follow-
up period to determine if any cardiovascular event had occurred.  The investigators 
suggested that FMD was a significant predictor of cardiovascular events, even after 
adjusting for baseline CVD status and CVD risk factors including age and gender.  Those 
individuals who had brachial artery FMD greater than the sex-specific medians were more 
likely to have event-free survival rates for cardiovascular events (Yeboah, Crouse, Hsu, 
Burke, & Herrington, 2007).  This study was also the first to suggest that brachial artery 
diameter was inversely related to the incidence of cardiovascular events in older 
individuals.  The relationship between FMD and baseline diameter size of the brachial 
artery was not shown in this study.  However, these findings are similar to those reported 
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by Shechter et al. (2007), indicating that although individuals with a larger brachial artery 
baseline diameter size may not experience maximal FMD, the vascular reactivity is still 
significantly larger than individuals who experience a follow-up cardiovascular event.  
This further supports the view that impaired FMD is a measure of the early “functional 
expression” of the atherosclerotic process, independent of the brachial artery baseline 
diameter size. 
To date, there are no known studies that have evaluated the prognostic impact of 
FBF assessed by strain gauge plethysmography in predicting the long-term outcome of 
individuals with and without CAD.  However, strain gauge plethysmography has been 
used to demonstrate relationships among FBF and several cardiovascular disease risk 
factors.  Ishibashi et al. examined FBF on individuals who were apparently healthy, with 
no known history of CVD and free from medications for hypertension, diabetes, and 
hyperlipidemia (Ishibashi et al., 2006).  Several cardiovascular disease risk factors were 
assessed, which included age, hypertension, hypercholesterolemia, diabetic mellitus, 
smoking, obesity, and a family history of CVD.  The investigators suggested that duration 
of hyperemia, when measuring FBF following the release of an upper arm cuff, was 
significantly shorter in individuals with CVD risk factors (Ishibashi et al., 2006).  Long-
term studies are warranted that evaluate the duration of hyperemia with clinically evident 
atherosclerotic disease later in life.    
Alarmingly, it is speculated that ED is present in asymptomatic children as 
suggested by the existence of fatty streaks in postmortem studies (Napoli et al., 1999).  As 
previously described, there is a strong relationship between ED and pro-inflammatory 
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conditions.  Children with acute respiratory infections, a pro-inflammatory state, have 
decreased brachial artery FMD that has been shown to be reversible (M. Charakida et al., 
2005).  However, chronic pro-inflammatory conditions, such as obesity can be significant 
in the initiation of atherosclerosis.  Due to ED being an early event in the progression of 
CVD, EF assessment could be of prognostic value since it reflects vascular biology.   
If ED is associated with the pathogenesis of CVD, it is often proposed that reversal 
of ED will reduce the risk for CVD.  Recently, Kitta et al. examined the effect of various 
medications used to treat CVD risk factors, along with suggested life-style changes, in 
evaluating improvements in brachial artery FMD and predicting future cardiovascular 
events (Kitta et al., 2009).  Brachial artery FMD was assessed before and after a six month 
period that consisted of optimized therapy.  At six months, approximately 58% of the 
individuals improved their FMD.  This change in FMD was seen in the absence of changes 
in baseline brachial artery diameter, baseline brachial artery blood flow, increased brachial 
artery blood flow, and increased brachial artery diameter after the infusion of NTG (Kitta 
et al., 2009).  Individuals with an improved FMD had a significantly higher survival rate 
without a cardiovascular event during a 36 month follow-up.  These findings support the 
application of serial FMD measurements as a tool to assess therapeutic options involved in 
improving vascular reactivity.  While subjects were advised to walk more than 30 minutes 
per day, an evaluation to measure adherence to physical activity (PA) was not included, 
making it difficult to articulate any benefits of PA in this particular study.   
EXERCISE TRAINING AND ENDOTHELIAL FUNCTION 
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The beneficial effects of exercise on reducing risk for CVD are well known.  
Studies that have assessed the effects of exercise on ED have strengthened decisions to 
employ exercise training as an important therapy treatment for ED.  As previously 
described, increasing shear stress on endothelial cells stimulates secretion of NO leading to 
smooth muscle cell relaxation and subsequent vascular dilation.  This led investigators to 
initially hypothesis that any improvement in ED from exercise would be location specific 
due to an increased blood flow to contracting muscles.  Kingwell et al. were the first to 
demonstrate in humans an enhanced resting NO production in an untrained limb following 
4 weeks of cycle training (Kingwell, Sherrard, Jennings, & Dart, 1997).  The researchers 
suggested that although no muscular adaptations occurred in the unexercised limb, there 
were systemic adaptations from exercise, including an increase in pulse pressure that 
enhanced the release of NO from non-trained vascular beds.  Aside from the 4 week 
training study, an exercise session consisting of 30 minute on a cycle was performed to 
assess single-arm post-exercise FBF through venous occlusion plethysmography.  Forearm 
blood flow was significantly increased after a single session of cycle exercise and 
remained elevated for approximately 60 minutes after cessation of exercise in a few of the 
subjects.  This data suggests that regular exercise using a large muscle mass can induce 
adaptations in non-exercising limbs, which enhance EF.  This important finding justifies 
the evaluation of FBF with common aerobic exercise modalities such as cycling and 
walking.   
As exercise in large muscle groups has been shown to have a systemic effect on the 
body, localized training in smaller muscle groups (i.e. forearm) may not be associated with 
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systemic effects.  Katz et al. examined the effect of exercise training on EF in adults with 
idiopathic dilated cardiomyopathy and congestive heart failure symptoms (Katz, Yuen, 
Bijou, & LeJemtel, 1997).  The subjects performed non-dominant hand grip exercises 30 
minutes per day for eight weeks.  Peak reactive hyperemic FBF post-training was 
significantly increased in the trained arm, but not the untrained arm.     
Exercise Training and EF in Subjects with CVD Risks 
Many studies have shown an exercise training effect on EF with subjects who were 
at higher risk for CVD.  Watts et al. evaluated the effect of exercise on EF during eight 
weeks of exercise training or eight weeks of non-training (Watts, Beye, Siafarikas, 
O'Driscoll et al., 2004).  The study recruited obese adolescents who either refrained from 
all activity or performed 1 hour sessions of circuit training 3 times per week for eight 
weeks.  Initially, brachial artery FMD was significantly different in obese versus normal 
control subjects.  FMD significantly increased in obese adolescents after 8 weeks of 
exercise training, which resulted in statistically similar FMD values between obese 
adolescents that trained and normal subjects.  Woo et al. examined the effect of diet alone 
versus diet with exercise on EF in overweight or obese adolescents (Woo et al., 2004).  
The diet intervention consisted of a hypocaloric menu that provided 900 – 1200 kcal a day.  
The exercise intervention consisted of circuit training exercise 2 times per week for 6 
weeks.  At the start of the study, overweight adolescents had an impaired brachial artery 
FMD compared to a non-obese control group.  Although both groups had an improvement 
in FMD at the end of the study, the diet and exercise intervention resulted in a significant 
improvement in FMD compared to the diet alone.  These changes in EF were not seen 
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following a sublingual dose of NTG, evidence that the changes in FMD were endothelium-
dependent.  Additionally, Hamdy et al. examined the effects of EF prior to and following a 
6 month diet and exercise intervention in obese adults who had MetS (Hamdy et al., 2003).  
The intervention consisted of a diet accounting for 500 kcal per day of negative energy 
balance with supervised exercise 3 days per week along with 150 minutes per week of 
unsupervised activity.  Baseline brachial artery diameter did not change during the 
intervention.  FMD was significantly improved after the 6 month intervention.  As shown 
in previously described intervention studies, sublingual administration of NTG did not 
result in significant differences in FMD at baseline compared to 6 months. 
More recently, Schjerve et al. investigated the effect of various exercise training 
modes and intensities on EF in obese individuals (Schjerve et al., 2008).  Subjects were 
randomized into three groups, which included strength training, moderate-intensity aerobic 
training, and high-intensity aerobic training.  Participants completed 12 weeks of exercise 
training, performing supervised sessions twice per week and one home-based session each 
week.  Aerobic exercise training was designed to control for caloric expenditure, as the 
high-intensity subjects performed 4x4-minute interval bouts at 85 – 95% maximal heart 
rate (HRmax) and the moderate-intensity subjects walked for 47 minutes at 60 – 70% of 
HRmax (Schjerve et al., 2008).  The strength training group performed four sets of 5 
repetitions at 90% 1 repetition max on a leg apparatus, in addition to three sets of thirty 
repetitions of abdominal and back exercises with a 30 second break between each set.  
Brachial artery FMD significantly increased after 12 weeks of training in all three exercise 
groups.  However, post-training FMD of the high-intensity group was significantly greater 
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than the moderate-intensity and strength training group.  The moderate-intensity and 
strength training group did not have a significantly different post-training FMD.  Baseline 
brachial artery diameter and blood flow was not significantly different between groups 
before training and did not change after 12 weeks of training.  Additionally, there was no 
significant difference in brachial artery FMD in response to nitroglycerin before or after 12 
weeks of training in any of the groups (Schjerve et al., 2008).  This study suggests that 
aerobic exercise training at high or moderate-intensity and strength training will improve 
EF in obese individuals.    
Moreover, studies have evaluated other cardiovascular risk factors in determining 
the exercise training effect on EF in various populations, such as hypertensives, diabetics, 
and hypercholesterolemics (Higashi et al., 1999; Maiorana et al., 2001; Walsh, Yong et al., 
2003).  Higashi et al. examined the effect of exercise training on EF in hypertensive 
subjects (Higashi et al., 1999).  The subjects performed 12 weeks of aerobic exercise, 
which consisted of brisk walking (52 ± 9% VO2) for 30 minutes 5 -7 times per week.  
After 12-weeks, both systolic and diastolic blood pressures were significantly decreased.  
FBF was significantly increased in response to the infusion of acetylcholine at 12 weeks.  
This response was abolished with the infusion of NG-monomethyl-L-arginine (L-NMMA), 
a known inhibitor of NO. The study proposed that the increased shear stress from increased 
flow was responsible for changes in NO production and subsequent increased FBF.   
Additionally, investigators have examined the effect of circuit exercise training on 
EF in subjects who are diabetic and those who are currently or have previously been 
hypercholesterolemic (Maiorana et al., 2001; Walsh, Yong et al., 2003).  An 8-week 
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training schedule was developed to target the larger muscle groups of the lower body.  
Each supervised exercise session lasted one hour, with participants alternating every 45 
seconds between seven resistance and eight aerobic exercise stations (Maiorana et al., 
2001).  Subjects were required to maintain 70 – 85% of HRmax while at the aerobic stations 
and lift 55 – 65% of their baseline maximal voluntary contraction at the resistance stations.  
Participants with a history of hypercholesterolemia had one at-home and two supervised 
weekly exercise sessions, while those with type 2 diabetes were instructed during three 
supervised weekly exercise sessions (Maiorana et al., 2001; Walsh, Yong et al., 2003).  At 
home, the subjects were encouraged to perform continuous aerobic exercise at 70 – 85% of 
HRmax for 45 – 60 minutes.   Investigators in both studies measured brachial artery FMD 
and FBF before training and then again at the end of the 8 week program.  FMD in 
response to 5 minutes of forearm ischemia significantly increased after 8 weeks of circuit 
training in both subjects with type 2 diabetes and those who had been treated for 
hypercholesterolemia (Maiorana et al., 2001; Walsh, Yong et al., 2003).  This change 
appeared to be endothelium dependent due to a similar non-significant FMD response to 
nitroglycerin.  FMD did not significantly improve after 8 weeks of circuit training in 
untreated hypercholesterolemic subjects (Walsh, Yong et al., 2003).  When comparing the 
ratio of flow to ACH in the infused arm to flow of the non-infused arm, FBF was 
significantly increased following 8 weeks of circuit training in subjects with type 2 
diabetes, as well as those who had been treated for hypercholesterolemia (Maiorana et al., 
2001; Walsh, Yong et al., 2003).  The increased FBF response to ACH following circuit 
training was not observed during the infusion of sodium nitroprusside (SNP), an 
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endothelial-independent vasodilator.  Likewise, infusion of L-NMMA in subjects who had 
been treated for hypercholesterolemia did not result in significant increases in FBF (Walsh, 
Yong et al., 2003).  Similar to Higashi et al. (1999), both Maiorana et al. (2001) and Walsh 
et al. (2003) proposed that the increased endothelial wall shear stress was primarily 
responsible for the increase in FMD and FBF following circuit training in subjects with 
type 2 diabetes, as well as those who had been treated for hypercholesterolemia. 
Interestingly, Green et al. investigated whether EF improvements observed with 
exercise resulted from short term repetitive exercise bouts or exercise associated 
improvements in CVD risk factor profiles (Green et al., 2003).  Eight weeks of circuit 
training as described above resulted in an enhanced exercise capacity, emphasized by 
significant increases in resting heart rate, maximal exercise test duration, and absolute and 
relative VO2peak.  Other significant changes that resulted from 8 weeks of circuit training 
included an increased muscular strength and decreased peripheral adiposity.  Eight weeks 
of circuit training did not significantly change plasma lipids, blood pressure, resting blood 
glucose, waist-to-hip ratio, or BMI (Green et al., 2003).  Brachial artery FMD and FBF, in 
response to 5 minutes of forearm ischemia and ACH infusion, respectively, were 
significantly increased after 8 weeks of circuit training.  Although exercise has been shown 
to have a systemic effect on EF, as described above, the study suggests that these changes 
in EF are not exclusively related to the effect that exercise has on CVD risk factors.  This 
further demonstrates the impact exercise training has on the vascular system, with its 
frequent, periodic increase in shear stress.               
Exercise Training and EF in CVD 
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 Several studies have evaluated the effect of exercise training on EF in subjects with 
cardiovascular disease.  Walsh et al. was the first to suggest that individuals with a history 
of coronary artery disease had improved EF in the brachial artery following eight weeks of 
circuit training as previously described (Walsh et al., 2003; Walsh, Yong et al., 2003).  As 
demonstrated in other subject populations with impaired EF, brachial artery FMD 
significantly increased after eight weeks of exercise training.  In keeping with previous 
studies described above, brachial artery response to NTG was not significantly different 
before versus after exercise. 
The effect of aerobic exercise training only on EF in patients with CVD has shown 
similar results.  Edwards et al. was the first to demonstrate significant improvements in 
brachial artery FMD in subjects with coronary artery disease following 12 weeks of 
aerobic exercise training (Edwards et al., 2004).  Participants exercised 3-times per week 
on a treadmill or stationary cycle, progressing intensity and duration, from 40 – 85% of 
HRmax reserve and 15 – 50 minutes, respectively. The investigators also reported a 
significant increase in plasma nitrate and nitrite levels following 12-weeks of exercise 
training, suggesting a plausible mechanism for the improvement in EF (Edwards et al., 
2004).  Additionally, as few as four weeks of aerobic exercise training has been shown to 
improve EF in patients with CAD (Sixt et al., 2008).  Subjects participated in supervised 
exercise sessions every day during the first week, followed by three weeks of a daily 
home-based exercise routine and supervised training sessions twice per week.  Study 
findings suggest that relative VO2 significantly improved without a concurrent loss in body 
weight after four weeks of exercise training.  Subjects who participated in four weeks of 
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exercise training also significantly improved brachial artery FMD, while no difference in 
FMD was observed after infusion of NTG (Sixt et al., 2008). 
Recently, Vona et al. investigated the effect of varying types of exercise training on 
EF in subjects who had recently experienced a myocardial infarction (Vona et al., 2009).  
Participants were randomly placed into one of four groups, which consisted of aerobic 
training, resistance training, combined training, or a control group.  Each group, aside from 
the controls, underwent supervised training sessions four times a week for four weeks.  
Brachial artery diameter and FMD during reactive hyperemia was not significantly 
different between groups at baseline (Vona et al., 2009).  After four weeks of training, 
brachial artery FMD significantly improved in all four groups, although significantly less 
in the control group.  The investigators suggested that the increase in FMD observed in the 
control group was more likely a secondary response to the maximal exercise test conducted 
a day prior.  Four weeks of exercise training, independent the mode of exercise appeared to 
improve EF in subjects who had recently experienced an uncomplicated myocardial 
infarction.          
Exercise Training and EF in Healthy Individuals                   
Although most exercise training studies have evaluated subjects with an increased 
risk for CVD disease, a limited number of studies, as described below, have evaluated the 
effect of exercise training on EF in healthy subjects.  Moreover, these studies are not in 
complete agreement that EF is enhanced following exercise training in healthy individuals.  
There are several studies that support an enhanced EF following exercise training in 
healthy individuals (Clarkson et al., 1999; Goto et al., 2003; Higashi et al., 1999; 
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Rakobowchuk et al., 2008).  However, there are also studies that suggest that EF is not 
significantly enhanced following exercise training and may even be impaired depending 
upon the intensity employed during training (Bergholm et al., 1999; Goto et al., 2003; 
Rakobowchuk et al., 2005).   
Initially, Higashi et al. assessed EF in healthy individuals following 12 weeks of 
aerobic exercise consisting of 30 minutes of brisk walking (52 ± 9% VO2max) 5 -7 times per 
week (Higashi et al., 1999).  Following 12 weeks of exercise, FBF was significantly 
increased in response to infused acetylcholine.  This increased FBF response was abolished 
with the intra-arterial infusion of L-NMMA.  Additionally, Clarkson et al. examined the 
effect of a 10-week basic military training camp on EF in 35 healthy males (Clarkson et al., 
1999).  Following exercise training, baseline vessel diameter of the brachial artery did not 
change compared to pre-training diameter size and brachial artery FMD during reactive 
hyperemia was significantly increased compared to pre-training values.  The authors 
suggested that exercise at a reasonable intensity would be beneficial in inducing vascular 
change and improving EF.  The military recruits performed a daily 3 mile run and 
undertook upper-body strength and endurance exercises.   
However, in contrast to the previously described studies, one study did not support 
an enhanced EF following exercise training.  Bergholm et al. evaluated the effect of a high-
intensity 12-week aerobic exercise study on EF in moderately fit males (BMI 21.8 ± 0.4 
kg/m2, VO2max 53 ± 2 ml/kg/min) (Bergholm et al., 1999).  The subjects participated in 
four, one hour running sessions per week at an intensity that matched 70 – 80% of their 
VO2max.  FBF in response to ACH significantly decreased after 12 weeks of intense 
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exercise training compared to measurements taken before training.  FBF in response to 
SNP was not significantly different in the subjects before compared to after the exercise 
training, suggesting the FBF response to intense exercise training was endothelium-
dependent (Bergholm et al., 1999).   
The inconsistent findings in exercise training effects on EF in healthy individuals 
led Goto et al. to investigate the effect of a 12 week exercise program using different 
exercise training intensities on EF (Goto et al., 2003).  There were no baseline significant 
differences between the three groups who participated in either mild (25% VO2max), 
moderate (50% VO2max) or high (75% VO2max) intensity exercise training.  Following 12 
weeks (30 minutes, 5-7 days each week) of aerobic exercise, only subjects who 
participated in moderate intensity exercise had an improvement in FBF following the 
infusion of acetylcholine.  The infusion of L-NMMA abolished these effects, supporting 
the release of NO as the cause for vasodilation.  The investigators suggested that the mild 
aerobic exercise was not a strong enough stimulus to attain a response, whereas high 
intensity aerobic exercise was associated with increasing biomarkers known to decrease 
the bioavailability of NO. 
Furthermore, Rakobowchuk et al. evaluated the effect of resistance exercise on EF 
in 28 healthy young men (Rakobowchuk et al., 2005).  The subjects completed a 12 week 
progressive protocol, exercising 5 times per week (60 sessions).  Brachial artery diameter 
and peak FMD during reactive hyperemia significantly increased after 6 weeks of training 
and remained elevated at 12 weeks.  However, peak and average shear rate in the brachial 
artery assessed through a linear array pulse Doppler ultrasound probe were not 
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significantly different at any point.  When brachial artery FMD was normalized for shear 
stimulus, there was no significant FMD change at any time during the training period.  
Although EF assessed by FMD did not change during 12 weeks of resistance training, the 
findings suggest that resistance exercise could represent a stable adaptation by enhancing 
resistance vessel function. 
Currently, studies appear to support an improvement in EF in healthy individuals 
following moderate-intensity aerobic exercise training.  These positive changes in EF with 
moderate-intensity training are not well supported in high-intensity aerobic exercise 
training or strength exercise training models.  Recently, Rakobowchuk et al. compared the 
effects of moderate-intensity aerobic training to high-intensity, low-volume, sprint interval 
training on EF (Rakobowchuk et al., 2008).  The authors suggested that both groups had a 
comparable significant improvement in FMD.  However, the measurement of FMD was 
different than in the studies previously described.  Rather than measure FMD in the 
brachial artery, the authors measured FMD in the popliteal artery.  The FMD response of 
the popliteal artery did not measure the systemic effects of the exercise training, rather the 
direct effects of a trained limb making it difficult to compare the results of this study to 
those previously reported.       
In 2008, Heylen et al. described the impact of exercise training frequency on EF in 
male Wister rats (Heylen et al., 2008).  The study suggested that the thoracic aorta’s 
sensitivity to ACH was significantly greater in rats that exercised at a moderate intensity 
five days per week, compared to one day per week of moderate PA.  The authors provided 
evidence that there is a frequency-dependent dose of moderate PA that will elicit 
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endothelial-dependent improvements in vascular reactivity.  Studies investigating the effect 
of exercise frequency training on EF are warranted in human populations, especially those 
individuals who are at increased risk for CVD, where exercise training appears to have an 
established effect on EF.       
ACUTE BOUTS OF EXERCISE AND ENDOTHELIAL FUNCTION 
While most studies examine EF following exercise training, EF following acute 
exercise has not been extensively researched.  Only a few studies have evaluated the effect 
of a single bout of exercise on EF in healthy individuals.  Initially, Baynard et al. recruited 
healthy adult men who were either endurance trained or resistance trained (Baynard, 
Miller, & Fernhall, 2003).  FBF was measured prior to and immediately after (5 minutes) a 
maximal exercise test measuring oxygen consumption.  Resting FBF was higher in the 
resistance trained group.  The endurance trained group had a higher resting reactive 
hyperemic FBF.  Following maximal exercise, reactive hyperemic FBF declined at slower 
levels compared to resting reactive hyperemic FBF in the endurance trained group.  The 
resistance trained group had significantly higher reactive hyperemic FBF following 
exercise compared to resting values.  A subsequent study examined FBF in subjects for 2 
hours following maximal exercise (Bousquet-Santos, Soares, & Nobrega, 2005).  FBF was 
measured prior to and 10, 60, and 120 minutes after maximal exercise in 9 healthy adults.  
Compared to resting values, baseline FBF was significantly increased at 10 minutes post 
exercise, but not 60 and 120 minutes post exercise.  Compared to resting values, reactive 
hyperemic FBF was significantly increased at 10 and 60 minutes post exercise, but 
returned to near baseline numbers at 120 minutes post exercise.  It is important to point out 
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that this study did not use peak FBF values rather the area under the curve following three 
minutes of FBF measurements.  These results are very similar to the FBF rate of decline, 
which may be controlled by a different mechanism than peak FBF.  Finally, Rognmo et al. 
recently investigated the effect of a single high-intensity exercise bout on brachial artery 
FMD in highly-trained endurance athletes (VO2max 75.9 ± 0.8 mL/kg/min) versus sedentary 
controls (VO2max 47.7 ± 1.7 mL/kg/min) (Rognmo et al., 2008).  The study consisted of 
subjects performing an exercise protocol on the treadmill which included a 15 minute 
warm-up (60 – 70% HRmax) and 5 intervals of high-intensity (90% HRmax) running for 3 
minutes.  During each interval, subjects performed an active recovery (60 – 70% HRmax) 
for two minutes.  Each subject had brachial artery FMD measured prior to, and 1, 24, and 
48 hours post exercise.  The authors suggested that baseline FMD was not significantly 
different between highly-trained endurance athletes and sedentary, healthy individuals 
(Rognmo et al., 2008).  FMD measured 1 hour after a single high-intensity exercise bout 
was significantly decreased compared to baseline values in highly-trained endurance 
athletes and only slightly decreased in the sedentary controls.  FMD did not significantly 
change in the sedentary control group following exercise and returned to baseline values in 
the highly-trained endurance athletes at 24 and 48 hours after exercise.  Brachial artery 
diameter was significantly larger in the highly-trained endurance athletes compared to the 
sedentary controls.  However, brachial artery diameter significantly increased 1 hour post-
exercise compared to baseline diameter measurements in both groups (Rognmo et al., 
2008).  Although there was a significant reduction in FMD in the highly-endurance trained 
group, the vessel diameter was most likely maximally dilated at 1 hour post-exercise, 
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decreasing shear stress and any subsequent vasodilatory effect.  The large diameter size 
observed in highly-trained endurance athletes is unlike that of individuals with coronary 
artery disease.  Rather, the decreased FMD after exercise in the highly-trained endurance 
group is attributed to an improved “functional” vessel.   
Harris et al. was the first to investigate the effects of a single exercise bout on EF in 
overweight individuals (Harris, Padilla, Hanlon, Rink, & Wallace, 2008).  Subjects were 
categorized as either trained or untrained depending on physical activity profiles and 
placed randomly in one of three groups, where they walked on a treadmill for 45 minutes 
at 25, 50, or 75% of maximal exercise capacity.  Brachial artery FMD was assessed prior 
to and 1 hour post exercise.  Baseline FMD was not significantly different between groups.  
Walking 45 minutes at varying exercise intensities did not significantly alter FMD in 
trained or untrained overweight individuals (Harris et al., 2008).  However, when FMD 
was normalized to reflect the absolute response to exercise, trained overweight individuals 
significantly improved FMD 1 hour after exercise and untrained overweight individuals 
significantly decreased FMD 1 hour after exercise. 
Likewise, Umpierre et al. was the first to investigate the effect of sub-maximal 
exercise on EF in subjects with chronic heart failure (Umpierre, Stein, Vieira, & Ribeiro, 
2009).  Subjects performed a single exercise bout for 25 minutes at 10% below a 
predetermined, second ventilatory threshold.  FBF was measured prior to, immediately 
after, 10, 30, 60 minutes, and 24 hours post-exercise.  FBF was not significantly different 
at baseline between individuals with chronic heart failure and healthy controls.  FBF 
significantly increased in chronic heart failure subjects in response to exercise immediately 
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after and 10 minutes post-exercise before returning back to baseline values at 30 minutes 
post-exercise (Umpierre et al., 2009).  FBF significantly increased in healthy controls in 
response to exercise immediately after, 10, and 30 minutes post-exercise before returning 
back to baseline values 60 minutes post-exercise.  Interestingly, there were no significant 
FBF differences between the two groups when FBF was increased above baseline.      
The studies above present important findings in further understanding the effects of 
acute exercise on EF.  However, an extensive review of literature has produced no study in 
which the extended time-course for EF following a single bout of maximal exercise is 
shown, especially in obese individuals.  As seen later in this review, there are studies that 
evaluate an extended time-course of inflammatory biomarkers following exercise that may 
have an effect on the EF.  This information would be of primary importance, especially 
when measuring EF in response to exercise training where maximal exercise tests are 
typically performed before and after the training intervention in an attempt to evaluate 
changes in maximal exercise capacity.  There does not appear to be an established optimal 
time before EF is assessed following a training program’s last exercise bout.  Previously, 
measures have varied between 24 and 72 hours after the final exercise bout.   
EXERCISE TRAINING AND ENDOTHELIAL DYSFUNCTION BIOMARKERS 
Several studies described below include the measurement of ED biomarkers that 
are provoked by exercise training.  In a study previously described, Hamdy et al. evaluated 
the effects of exercise training on adhesion molecules ICAM-1 and VCAM-1 in subjects 
with MetS (Hamdy et al., 2003).  Following exercise training, ICAM-1 was significantly 
reduced while there was no change in VCAM-1.  ICAM-1 is associated with the 
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development of atherosclerosis through enhancement of foam cell formation and any 
improvement in blood concentration could potentially be linked to a risk reduction in the 
development of CVD.  Additionally, Niebauer et al. examined the relationship between 
eight weeks of exercise training and inflammatory cytokines in subjects with chronic heart 
failure (Niebauer, Clark, Webb-Peploe, & Coats, 2005).  During the eight weeks, subjects 
cycled on a home ergometer for 20 minutes at 70 – 80% of HRmax.  The investigators 
suggested that there was no effect of exercise training on TNF-α, IL-6, and ICAM-1 in 
both subjects with chronic heart failure and age-matched healthy controls (Niebauer et al., 
2005).  Furthermore, Stewart et al. examined the influence of exercise training on 
inflammatory markers IL-6, TNF-α, and CRP in young and old subjects who were 
physically active and inactive, but otherwise healthy (Stewart et al., 2007).  The 12 week 
training intervention consisted of circuit training performed 3 days per week.  When 
comparing all groups, there was no significant difference in IL-6 and CRP baseline 
concentrations.  TNF-α concentration was significantly higher in younger subjects at 
baseline, independent of being physically active or inactive.  Following exercise training, 
the young and old physically inactive had a significant decline in CRP levels.  There was 
no exercise training effects on TNF-α or IL-6 in any group.  Previous findings from Fisher 
et al. agreed that no relationship existed between TNF-α levels and PA (Fischer, Berntsen, 
Perstrup, Eskildsen, & Pedersen, 2006).  However, self-reported qualitative assessments of 
PA suggested a significant negative linear association with PA and pro-inflammatory 
cytokines, CRP and IL-6 (Fischer et al., 2006).   
ACUTE EXERCISE AND ENDOTHELIAL DYSFUNCTION BIOMARKERS 
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Few studies have evaluated the effect of acute exercise on biomarkers associated 
with atherosclerosis.  Kinugawa et al. examined the effect of maximal exercise on plasma 
TNF-α and IL-6 in subjects with CVD (Kinugawa et al., 2003).  At baseline, subjects with 
CVD had significantly higher levels of plasma TNF-α and IL-6 as compared to healthy 
controls.  Baseline plasma TNF-α and IL-6 had a significant positive correlation with 
norepinephrine levels and a significant negative correlation with VO2peak.  Maximal 
exercise significantly increased plasma TNF-α and IL-6 in subjects with CVD and healthy 
controls.  Additionally, von Kanel et al. compared the result of acute exercise on 
atherosclerotic risk markers and suggested that mean arterial blood pressure and VO2peak 
were independently associated with plasma ICAM-1 and IL-6, respectively (von Kanel, 
Hong, Pung, & Mills, 2007).  After a 20 minute sub-maximal exercise test on the treadmill, 
plasma IL-6 and ICAM-1 were both significantly higher than baseline.  However, after 25 
minutes post-exercise, plasma ICAM-1 declined to baseline values while IL-6 was 
significantly higher than post exercise values.  Finally, in a study previously described, 
Harris et al. examined the effect of a single bout of exercise at various intensities on 
plasma TNF-α and IL-6 levels one hour post-exercise in overweight trained and untrained 
men (Harris et al., 2008).  The authors suggested that baseline plasma TNF-α was not 
significantly different between trained versus untrained overweight men and that exercise 
did not significantly alter plasma TNF-α in either group independent of the exercise 
intensity.  Plasma IL-6 was not significantly different at baseline between trained versus 
untrained overweight men.  However, both groups had a comparable significant increase in 
plasma IL-6 after participating in moderate and high intensity exercise (Harris et al., 2008). 
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To date, there are no known studies that evaluate the extended time course of 
inflammatory markers after a single bout of exercise.  In 2007, a study by Louis et al. 
provided evidence that suggests the extended evaluation of inflammatory markers after 
exercise may be essential in the understanding of time controlled release of specific 
cytokines (Louis, Raue, Yang, Jemiolo, & Trappe, 2007).  The extended evaluation of 
inflammatory markers may also provide a much better understanding in the evaluation of 
vascular reactivity after exercise.  Louis et al. investigated the TNF-α mRNA and IL-6 
mRNA expression changes following a single aerobic exercise bout, which consisted of 
running for 30 minutes on the treadmill at 75% of each subject’s VO2max (Louis et al., 
2007).  TNF-α mRNA was significantly elevated immediately after exercise and again 12 
and 24 hours after exercise.  IL-6 mRNA was significantly elevated immediately after 
exercise and again 2, 4, 8, 12, and 24 hours after exercise.          
CONCLUSION 
The critical effect of endothelial wall activation and its associated role in initiating 
atherosclerosis warrants further research of the mediating receptors and circulating agents 
that allow for the control of vascular homeostasis.  Assessing EF and the biomarkers 
associated with its control is vital in understanding interventions that may help not only 
slow the progression of CVD but negate specific CVD risk factors.  The underlying 
mechanisms that control EF changes following exercise training have received a large 
amount of attention and continue to be evaluated.  PA has been shown as an important 
mediator for improving EF through the generation of shear stress.  Current research 
supports the importance of NO on vasodilation and previous studies agree with the role 
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shear stress plays in stimulating NO release from endothelial cells, contributing to the 
increased vascular blood flow during exercise.  Technical considerations in the assessment 
of exercise induced alterations of EF are beneficial in contributing to the proposed 
mechanisms of adaptation. 
  Direct non-invasive tools used to assess EF include high resolution vascular 
ultrasonography and venous occlusion strain-gauge plethysmography.  These tools allow 
researchers to mimic the shear stress which is often associated with exercise.  Inflatable 
cuffs wrapped around the upper arm and wrist allow for control of blood flow in the 
forearm.  Turbulent shear stress can be generated following a brief period of ischemia due 
to cuff inflation.  The reactive hyperemia has been closely associated with NO availability 
and the change from baseline in FBF and FMD are directly related to EF. 
During the assessment of EF, an intra-arterial catheter can be used to infuse 
different agents such as acetylcholine and L-NMMA.  Sublingual doses of nitroglycerin 
are also commonly used during the assessment of EF.  These agents have helped 
researchers characterize the role of endothelial cells in mediating vascular relaxation and 
have strengthened the role NO has on EF.  Unfortunately, many laboratories do not have 
the means, for various reasons, to access these clinical drugs.  This emphasizes the 
importance in understanding various mechanisms that control for NO availability.  
Biomarkers, such as TNFα, IL-6, ET, and CRP, can be easily measured and are suggested 
to be directly involved in the regulation of NO availability. 
Myokines, known as cytokines released from skeletal muscle, are generally 
secreted in response to PA.  Although several cytokines will soon be acknowledged as 
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myokines, only one cytokine has been recognized as a myokine.  IL-6 is known to have 
numerous secretion sites, including adipose and skeletal tissue.  Acute exercise studies 
support the role of cytokines released from areas other than adipose tissue and as described 
in this review, it is proposed that myokines may have different functional roles than 
adipokines.  Myokines may help support the well understood mechanics of glucose 
homeostasis during exercise and increased blood flow to contracting muscles in need of 
more oxygen.      
Future research directions include an extended time course of acute exercise-
induced adaptation on EF.  The time course of exercise induced adaptations on EF has 
been evaluated in only a few studies giving rise to the need for a similar study in healthy 
and obese subjects.  Exercise training study results are inconclusive as to whether the 
exercise interventions improve EF or whether improvements in EF are simply a reflection 
of the alterations from the last exercise bout performed.  A study designed to address this 
issue would be beneficial in establishing an optimal time point to assess EF following an 
exercise training program.  Findings may also allow researchers to further understand the 
impact an acute exercise bout can have on regulating the vasodilatory capacity of the 
arterial wall. 
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THE EXTENDED TIME COURSE OF FOREARM BLOOD FLOW 
 FOLLOWING A SINGLE MAXIMAL BOUT OF EXERCISE 
 
Abstract 
Chronic exercise is thought to improve endothelium-dependent vasodilation; 
however, studies evaluating endothelial dysfunction (ED) following an exercise training 
program lack a standardized time frame in which to measure vascular function (VF).  
Although most studies require subjects to abstain from exercise for 24 hours prior to any 
VF measures, no study to date has assessed VF longer than 24 hours after the cessation of 
exercise.  Purpose: To evaluate VF, as determined by the assessment of forearm blood 
flow (FBF) and vascular reactivity (VR) before and up to 48 hours after a single bout of 
maximal exercise in healthy male volunteers.  Methods: Twelve male subjects volunteered 
to participate.  FBF was assessed before and during reactive hyperemia (RH).  FBF 
measures were obtained prior to (PRE-E), immediately after (POST-E), and at 1 (POST-1), 
2 (POST-2), 24 (POST-24), and 48 (POST-48) hours after exercise.  Total excess flow, 
calculated as the difference between baseline FBF and FBF during RH, was used as an 
indicator of VR.  Blood samples were also obtained at each time point to evaluate the 
response of interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α), which are 
potential modifiers of VF.  Results: Baseline FBF and FBF during RH were significantly 
(P < 0.05) increased POST-E before returning to baseline values by POST-1.  VR was 
significantly (P < 0.05) increased POST-E and was not significantly (P < 0.05) reduced 
until POST-48.  Concentrations of IL-6 and TNF-α were unchanged in response to 
exercise.  Conclusions: These results suggest that measurements used to verify 
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improvements in VF following exercise training should be employed after a minimum of 
48 hours following physical activity. 
Introduction 
In healthy individuals, the quiescent state of the vascular system is maintained by 
vasoactive compounds produced by endothelial cells.  These compounds are responsible 
for cellular adhesion, thromboresistance, smooth muscle cell proliferation, vessel wall 
inflammation, and most importantly, modulating vascular tone (5).  Reduced endothelium-
dependent vasodilation, also known as endothelial dysfunction (ED), is associated with the 
early sub-clinical stages of atherosclerosis and often the result of a decreased nitric oxide 
(NO) bioavailabity (12, 18).  Several inflammatory bio-markers, including tumor necrosis 
factor-α (TNF-α) and interleukin-6 (IL-6), are directly related to NO bioavailability and 
subsequently, vascular function (VF) (14, 15, 22).  TNF-α has been shown to inhibit NO 
release from endothelial cells and degrade nitric oxide synthase mRNA, which can lead to 
an impairment of endothelium-dependent vasodilation (15, 22).  The role of IL-6 has 
recently received renewed attention as its origin of secretion is now thought to determine 
its function.  Whereas IL-6 released from adipose tissue is associated with an increase in 
the pro-inflammatory marker C-reactive protein (15), IL-6 secreted from contracting 
skeletal muscle is associated with the stimulation of anti-inflammatory cytokines and 
inhibition of TNF-α (14).  Furthermore, exercise training studies do not support a change 
in resting TNF-α or IL-6 concentrations (13, 19).   
TNF-α and IL-6 concentrations have been shown to significantly increase 
immediately following acute exercise in healthy individuals, as well as those with 
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inflammatory disease (10).  However, there are no studies that evaluate the extended time 
course of inflammatory markers after a single bout of exercise.  Louis and colleagues 
recently demonstrated that TNF-α mRNA in muscle was significantly elevated 
immediately after acute exercise, as well as at 12 and 24 hours post-exercise (11).  
Likewise, IL-6 mRNA in muscle was significantly elevated immediately after acute 
exercise, and at 2, 4, 8, 12, and 24 hours post-exercise.  An extended evaluation of 
inflammatory markers after acute exercise may contribute to a further understanding of the 
mechanisms influencing changes in VF following exercise. 
Chronic aerobic exercise training is thought to improve ED with much of the 
improvement in the vasodilatory capacity being attributed to the effects of an increase in 
exercise-induced shear stress production of NO (7, 8, 21).  However, studies evaluating ED 
following an exercise training program lack a standardized time frame in which to measure 
VF following the final training bout.  There are no studies that have included a specified 
amount of time after training to measure VF, with most reporting an abstinence of exercise 
for 24 hours (6-8, 17, 21, 23). 
Few studies have evaluated the effect of acute exercise on VF.  Bousquet-Santos 
and colleagues evaluated VF by measuring forearm blood flow (FBF) and vascular 
reactivity (VR) in healthy sedentary volunteers for two hours following a maximal exercise 
bout (4).  VR, calculated as the excess blood flow following a 5 minute bout of ischemia, 
was significantly elevated immediately after exercise and remained elevated for an hour, 
before returning to baseline within two hours of exercise.  Likewise, Umpierre and 
colleagues measured FBF in stable chronic heart failure (CHF) patients and healthy 
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controls up to 24 hours after a sub-maximal exercise bout (20).  Although no significant 
differences in FBF were seen between the groups across time, the FBF in CHF patients and 
healthy volunteers were back to baseline within 30 and 60 minutes, respectively. 
Neither of the aforementioned studies that evaluated FBF after exercise assessed 
inflammatory markers, which as previously stated, may affect prolonged post-exercise 
FBF measures.  Therefore, the purpose of this study was to evaluate an extended time 
course of FBF and vascular reactivity (VR) changes following a maximal aerobic bout of 
exercise for up to 48 hours.  Additionally, we aimed to evaluate the changes in blood 
markers associated with vascular endothelium activation following maximal exercise to 
further understand possible contributions to FBF response.  
Methods 
Subjects 
 
Thirteen apparently healthy male subjects between the ages of 20 and 25 years 
volunteered to participate in this study.  Subjects were excluded if they were smokers, had 
been diagnosed with diabetes or high blood pressure, had any form of known 
cardiovascular disease, or were taking medications that would potentially affect vascular 
function.  Subjects were also excluded if they were participating in high levels of physical 
activity as determined by the International Physical Activity Questionnaire at the time of 
the study.  Subjects were instructed to refrain from exercise for 3 days prior to the start of 
the study and during the course of the study.  Subjects were also instructed to refrain from 
alcohol and caffeine for 24 hours prior to testing and during the 3 days of testing.  Written 
informed consent was obtained from each subject before participation in the study.  All 
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procedures were approved by Virginia Commonwealth University’s Institutional Review 
Board.   
Study Design 
 
Subjects were instructed to report to the Human Performance Laboratory at 6:30 
a.m. following an overnight fast.  Subjects completed a medical history questionnaire and 
physical activity readiness questionnaire (PAR-Q) prior to the start of testing.  
Additionally, a physical activity diary was employed during the course of the study to 
evaluate physical activity outside of the study protocol.  After a 30-min rest period, a 7 ml 
blood sample was obtained from an anticubital vein.  Body composition was assessed with 
dual-energy x-ray absorptiometry (DXA; Lunar iDXA, GE Healthcare, Madison, WI).  
Resting heart rate (HR), blood pressure (BP), and FBF measures were taken prior (PRE-E) 
to the maximal exercise test.  Blood samples and subsequent BP and FBF measures were 
taken immediately after exercise (POST-E) and 1 (POST-1), 2 (POST-2), 24 (POST-24), 
and 48 (POST-48) hours after the cessation of exercise.  All FBF measures were taken on 
the right arm, opposite of all blood sampling.  All subjects were asked to remain in the 
laboratory until after the 2 hour post-exercise measurements.  On days 2 and 3, subjects 
reported to the laboratory following an overnight fast 30 minutes prior to times 
corresponding to 24 and 48 hours after the cessation of exercise, respectively.  A blood 
sample, BP, and FBF were taken following a 30-minute rest period.      
Maximal Exercise Protocol 
 
 Each subject was fitted with a heart rate monitor and respiratory gas analysis 
equipment (VMAX Spectra, Sensormedics Corp., Yorba Linda, CA) before completing a 
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graded exercise test to exhaustion on a treadmill.  Following a 3-minute warm-up period, 
the treadmill speed was increased to elicit 80% of each individual’s age-predicted maximal 
heart rate within 4 minutes.  Thereafter, grade was increased by 2% every 2 minutes until 
the subject could no longer maintain the treadmill pace.  The protocol was designed to last 
8 – 12 minutes.  Heart rate was obtained every minute and rating of perceived exertion 
(RPE) was obtained once every exercise stage.  Following an immediate blood pressure 
measurement, a 1-minute post-exercise capillary blood lactate sample (Lactate Scout, 
Sports Resource Group, Inc.) was obtained and used as a partial criterion to ensure that the 
subject gave a maximal effort.  Breath-by-breath oxygen consumption was averaged every 
10 seconds and the highest averaged value was identified as the maximal oxygen 
consumption (VO2max).   
Forearm Blood Flow Measurement 
 
Forearm blood flow (FBF) was assessed using mercury-in-rubber strain-gauge 
plethysmography (MSGP; Model AI6, D.E. Hokanson, Inc., Bellevue, WA).  Blood 
pressure cuffs were positioned around each subject’s upper right arm and right wrist, and a 
mercury-in-rubber strain gauge was placed around the forearm approximately 10 cm distal 
to the olecranon process (1).  During each trial, the wrist cuff was inflated to a pressure of 
240 mmHg prior to each measurement to occlude hand circulation.  Baseline FBF was 
determined by rapidly inflating the upper cuff to 40 mmHg for 10 seconds to occlude 
venous flow during a 20 second cycle.  Nine measurements were recorded to determine the 
average rate of volume change during venous occlusion (ml/100 ml of forearm tissue 
volume/min).  Subsequently, the upper arm cuff was inflated to 240 mmHg to induce 
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forearm ischemia for a period of 5 minutes.  After 5 minutes of occlusion, the cuff was 
released and FBF, as described above, was determined during a 3-minute period of reactive 
hyperemia (RH).  Total FBF, both at baseline and during RH were assessed as an area 
under the curve (AUC), calculated as a flow-time index.  Vascular reactivity (VR), 
indicated by total excess blood flow above baseline, was calculated as total FBF during RH 
minus total FBF at baseline.    
Biochemical Analyses 
 
Blood samples for analysis of TNF-α and IL-6 were collected into serum separator 
tubes and allowed to clot for 30 minutes before being centrifuged for 15 minutes at ~1000 
x g.  Serum was immediately aliquoted into microtubes and stored at -80°C until analyzed.  
Concentrations of TNF-α and IL-6 were determined through enzyme high-sensitivity 
immunoassay according to manufacturer’s specifications (R&D Systems, Minneapolis, 
MN).  All samples were run in duplicate and the mean concentration of each sample was 
used in statistical analysis. 
Statistical Analyses   
 
 A one-way ANOVA (SPSS, Chicago, IL: V17.0) was used to determine the impact 
of a maximal exercise test on FBF, VR, and serum cytokine (IL-6 and TNF-α) 
concentration changes across six different time periods (PRE-E, POST-E, POST-1, POST-
2, POST-24, and POST-48).  When indicated by a significant F-ratio, a Bonferroni post-
hoc analysis was performed to identify differences.  Additionally, Pearson product-
moment correlations were utilized to evaluate relationships among cardiorespiratory fitness 
values, vascular function, and cytokine (IL-6 and TNF-α) responses following the maximal 
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effort.  Descriptive statistics were used to illustrate subject demographics and exercise-
induced physiological variables to the maximal bout of exercise.  All data are expressed as 
mean ± SEM unless otherwise noted.  Statistical significance was set at P < 0.05. 
Results 
Subject Characteristics and physiological responses to acute maximal exercise 
 Of the thirteen subjects that volunteered for this study, one individual requested to 
withdraw from the study due to an aversion to the blood sampling procedures.  Therefore, 
12 subjects were used in the final analyses.  Subject characteristics are presented in Table 
1.  Table 2 provides the physiological responses to the maximal exercise test.  The total 
duration of the maximal exercise test did not include the warm-up.  One volunteer had 
difficulty breathing through the respiratory gas sensor and had the flow sensor removed 
during the maximal exercise test, however the subject continued with the protocol until 
expressing volitional fatigue.  Therefore, 11 subjects were used for all VO2max data 
analyses.      
FBF in response to acute maximal exercise 
 The AUC for FBF at baseline and during RH are shown in Figures 1 and 2, 
respectively.  A one-way ANOVA revealed a significant F-ratio for FBF, both at baseline 
and during RH, across time (P = 0.0001 and P = 0.001, respectively).  A Bonferroni post-
hoc analysis revealed that FBF, at baseline and during RH, was significantly (P < 0.0001) 
elevated POST-E compared to PRE-E, before returning to baseline values within POST-1 
(P < 0.01, POST-E vs. POST-1).  FBF, at baseline and during RH, remained at values 
similar to PRE-E at POST-2, POST-24, and POST-48.  VR, expressed as total excess 
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blood flow, is shown in Figure 3.  A one-way ANOVA revealed a significant (P = 0.014) 
F-ratio for VR across time.  Furthermore, a Bonferroni post-hoc analysis revealed that VR 
was significantly elevated (P = 0.017) POST-E compared to PRE-E.  VR remained 
elevated, although not significantly different from PRE-E, at POST-1, POST-2, and POST-
24 before returning to values at POST-48 significantly (P = 0.044) lower than POST-E.    
 Moreover, VR PRE-E was not significantly correlated to VO2max per lean muscle 
mass (r = 0.348, P = 0.295).  However, VR PRE-E was significantly correlated to BMI (r = 
.749, P = 0.005), fat mass (r = 0.812, P = 0.001), and percent fat (r = 0.651, P = 0.022).   
IL-6 and TNF-α response to acute maximal exercise 
 Figure 4 illustrates the IL-6 and TNF-α response to acute maximal exercise.  A one-
way ANOVA revealed that IL-6 and TNF-α were not significantly different across time (P 
= 0.173 and P = 0.653, respectively).  Additionally, IL-6 and TNF-α were not significantly 
correlated to VR across time (r = 0.050, P = 0.678 and r = 0.172, P = 0.158, respectively).  
The mean coefficient of variation for all IL-6 and TNF-α samples run was 17.98 ± 2.00% 
and 10.94 ± 1.03, respectively. 
Discussion 
This is the first study that has evaluated FBF and VR at time points up to 48 hours 
after a single maximal bout of aerobic exercise.  The main finding of this study was that 
VR following a single maximal bout of aerobic exercise was not significantly reduced 
from the immediate post-exercise measure until 48 hours after the cessation of exercise.  
FBF and FBF during RH significantly increased immediately after exercise, before 
returning to pre-exercise levels within 1 hour of exercise.  Additionally, IL-6 and TNF-α 
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did not significantly change from baseline values for the duration of this study.  However, 
IL-6 did increase up to 2 hours following exercise, before decreasing below pre-exercise 
concentrations.       
 Similar to other studies measuring FBF and VR following an acute aerobic exercise 
bout, our study did show an increase in FBF and VR immediately following exercise (2-4, 
9).  Kingwell and colleagues demonstrated an increase in FBF immediately following 30 
minutes of cycling at 65% of VO2max in healthy individuals (9).  However, it is unclear 
how long the increase in FBF lasted after exercise, as the investigators only presented 
results from three subjects who continued to have an increased FBF at 60 minutes post 
exercise.  FBF and VR have been measured after a maximal exercise test in only two other 
studies.  Bousquet-Santos and colleagues demonstrated a significant increase in FBF 
during RH and VR immediately following a maximal exercise test in healthy sedentary 
individuals (4).  The increase in FBF during RH and VR were still significantly elevated at 
1 hour post exercise before returning to baseline levels within 2 hours post exercise.  It is 
important to note that our healthy males had a greater cardiorespiratory fitness level, 
demonstrated by a greater relative VO2max (50.9 ± 1.1 vs. 44.8 ± 2.1, mlO2/kg/min), than 
those previously reported.  Rognmo and colleagues speculated that lower fitness levels 
were often associated with smaller arteries that may have a greater vascular dilation 
response due to an increased hyperemic shear stress (16).  The previously reported FBF 
during RH and VR that was significantly increased 1 hour after maximal exercise may 
have been attributed to a subject population with smaller arteries and a subsequent greater 
hyperemic shear stress.  Baynard and colleagues evaluated the difference in FBF during 
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RH in resistance trained versus endurance trained men following a maximal exercise test 
(2, 3).  FBF during RH was significantly elevated immediately after exercise in resistance 
and endurance trained individuals.   
 IL-6 and TNF-α were not significantly different at any time point up to 48 hours 
following a maximal bout of aerobic exercise.  This finding is in contrast to previous 
reports that have demonstrated a significant increase in IL-6 and TNF-α following a 
maximal bout of exercise (10).  Additionally, Louis and colleagues recently suggested that 
the concentration of IL-6 and TNF-α mRNA cytokine release in response to exercise 
varied significantly up to 48 hours post-exercise (11).  An acute sub-maximal bout of 
aerobic exercise significantly increased IL-6 mRNA immediately and 4, 8, 12 and 24 hours 
post-exercise.  TNF-α mRNA demonstrated a temporal response to exercise as well with 
significant increases immediately and 2, 12, and 24 hours following an acute sub-maximal 
bout of aerobic exercise.  Louis and colleagues did not determine the functional protein 
expression translated from the increased mRNA markers following acute aerobic exercise.  
Any change in IL-6 and TNF-α during an extended time-course following exercise could 
affect endothelium-dependent vasodilation.  However, the IL-6 and TNF-α responses to 
acute exercise in the current study suggest that FBF and VR at rest and following a single 
maximal aerobic bout of exercise are independent of the response of these blood markers 
in healthy males. 
These results must be viewed within the context of this study’s limitations.  We did 
not measure the size of the arteries in the forearm under investigation, therefore can not 
conclude that variation in shear stress was responsible for differences seen in our study 
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compared to results previously reported.  It is also important to note that we did not take a 
sample of blood between our immediate post-exercise measure and 1 hour after exercise 
and are unable to conclude that a shortened inflammatory response did not occur within 
our measurement period.  Additionally, if the functional protein expression of IL-6 and 
TNF-α varied following exercise in a similar response to the mRNA expression previously 
indicated, then measurement time becomes crucial in determining a change in biomarker 
activity.  Lastly, although the sample size for this study is small, it is in accordance with 
other studies investigating this area of research (2-4, 16, 20).   
In conclusion, a single maximal bout of aerobic exercise resulted in an immediate 
increased VR that did not significantly reduce from the immediate post-exercise value until 
48 hours after exercise.  Additionally, FBF at baseline and during RH significantly 
increased immediately after exercise before falling to pre-exercise values within 1 hour.  
These changes in FBF and VR following exercise demonstrate that although healthy males 
have an increased vascular conductance immediately after exercise, they also have a 
significantly enhanced reactive vasodilation immediately following exercise.  Although 
VR at 1, 2, 24, and 48 hours after exercise were not significantly different from pre-
exercise values, these results suggest that any increase observed in VR up to 24 hours after 
exercise may be directly due to the previous exercise bout.  We did not measure VR 
between 24 and 48 hours and can not speculate any changes that may have occurred 
between those two measurement periods.  Exercise training studies that may use VR as an 
assessment of vascular improvements following exercise need to be cautious in taking pre 
and post measurements at different times of the day due to any diurnal variations that could 
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exist.  Therefore, although further research is necessary to understand VF following a 
single maximal bout of aerobic exercise, this study recommends that any measurement 
used to assertively elucidate improvements in VF following exercise training should be 
performed at least 48 hours after the last exercise session.  IL-6 and TNF-α did not change 
in response to a single maximal bout of exercise and do not support the changes seen in 
FBF following the exercise session.  Future studies are warranted that investigate the acute 
extended time course effects of various exercise intensities and VR measurement times in 
healthy individuals. 
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Table 1 Subject characteristics, N = 12 
Variable                  Mean ± SEM   
Age (years)                    21.6 ± 0.4         
Weight (kg)                             67.8 ± 2.8       
BMI (kg/m2)         21.9 ± 0.3        
Percent Fat (%)        19.8 ± 1.4        
Fat Mass (kg)         13.0 ± 1.2        
Lean Mass (kg)        51.9 ± 1.9        
Resting HR (bpm)        56.0 ± 2.2        
Resting SBP (mm Hg)                          119.3 ± 4.2       
Resting DBP (mm Hg)       66.6 ± 2.1 
Baseline TNF-α (pg/mL)         1.2 ± 0.1 
Baseline IL-6 (pg/mL)         1.3 ± 0.5       
BMI, Body Mass Index; HR, Heart Rate; SBP, Systolic Blood Pressure; DBP, Diastolic 
Blood Pressure; TNF-α, Tumor Necrosis Factor – alpha; IL, Interleukin.  
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Table 2 Physiological responses to acute maximal exercise, N = 12 
Variable        Mean ± SEM     
Maximal Lactate (mmol/L)                   10.6 ± 0.7           
Maximal RPE                              19.5 ± 0.1         
Maximal HR (bpm)                 195.9 ± 2.3       
Testing Time (s)                 709.9 ± 33.6       
Relative VO2max (mLO2/BM/min)       50.9 ± 1.1        
Relative VO2max (mLO2/LM/min)       66.1 ± 1.2 
Absolute VO2max (LO2/min)            3.4 ± 0.1        
RPE, Rating of Perceived Exertion; HR, Heart Rate; VO2max, Maximal Oxygen 
Consumption; BM, Body Mass (kg); LM, Lean Mass (kg).  
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Figure 1.  Forearm blood flow during baseline calculated as the area under the curve 
(mean ± SEM).  *p<0.05 vs. PRE-E, †p<0.05 vs. POST-E.
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Figure 2.  Forearm blood flow during reactive hyperemia calculated as the area under the 
curve (mean ± SEM).  *p<0.05 vs. PRE-E, †p<0.05 vs. POST-E. 
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Figure 3.  Vascular reactivity, calculated as total RH FBF minus total baseline FBF (mean 
± SEM).  *p<0.05 vs. PRE-E, †p<0.05 vs. POST-E. 
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Figure 4.  The effect of acute maximal exercise on serum concentrations of IL-6 and TNF-
α (mean ± SEM).   
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FOREARM BLOOD FLOW RESPONSE TO AN ACUTE MAXIMAL EXERCISE 
BOUT IN OBESE AND NORMAL WEIGHT MALES 
 
Abstract 
 
 One of the earliest sub-clinical stages associated with atherosclerosis is endothelial 
dysfunction (ED), which has been shown to predict future cardiovascular events.  Chronic 
exercise is thought to improve endothelium-dependent vasodilation; however, few studies 
have evaluated the effects of acute exercise on vascular function (VF).  In addition, no 
studies have compared VF responses in obese and non-obese individuals following acute 
exercise.  Purpose: To evaluate VF, as determined by the assessment of forearm blood 
flow (FBF) and vascular reactivity (VR) before and up to 48 hours after a single bout of 
maximal exercise in obese and non-obese males.  Methods: Twelve obese (37.0 ± 1.1 
kg/m2) and twelve non-obese (21.9 ± 0.3 kg/m2) males volunteered to participate.  FBF 
was assessed before and during reactive hyperemia (RH).  FBF measures were obtained 
prior to (PRE-E), immediately after (POST-E), and at 1 (POST-1), 2 (POST-2), 24 (POST-
24), and 48 (POST-48) hours after exercise.  Total excess flow, calculated as the difference 
between baseline FBF and FBF during RH, was used as an indicator of VR.  Blood 
samples were also obtained to evaluate the response of interleukin-6 (IL-6) and tumor 
necrosis factor alpha (TNF-α), which are potential modifiers of VF.  Results: Baseline 
FBF and FBF during RH were significantly (P < 0.05) increased in both groups POST-E 
before returning to baseline values by POST-1.  VR was enhanced in both groups POST-E, 
although the magnitude of change was significantly greater in non-obese males.  
Concentrations of IL-6 and TNF-α were unchanged in response to exercise in both groups.  
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Conclusions: An acute bout of maximal exercise significantly increased forearm 
endothelium-dependent vasodilation in non-obese and obese males.  Additionally, an 
increased reactive vasodilation was observed only in non-obese males following exercise. 
Introduction 
The most recent prevalence report of overweight and obesity in the United States 
estimates that the incidence of obesity has continued to rise, as 32.2% of all individuals 
over the age of 20 years are classified as obese (21).  This is particularly alarming given 
that obesity is widely considered an independent risk factor for cardiovascular disease 
(CVD) (23).  Atherosclerosis, a group of diseases distinguished by arterial wall thickening, 
accounts for approximately three-fourths of all CVD deaths (27).  Additionally, 
atherosclerosis is a progressive condition where pathological changes will occur many 
years earlier in arteries prior to the onset of adult clinical symptoms.  One of the earliest 
sub-clinical stages in the atherosclerotic process is the impairment of endothelium-
dependent vasodilation, also known as endothelial dysfunction (ED) (29).  ED can be 
detected prior to the development of atherosclerotic plaques in both coronary and 
peripheral vessels and has been associated with the pathogenesis of numerous CVD risk 
factors (7).  The assessment of vascular function can therefore be useful in detecting the 
onset of atherosclerosis, quantifying cardiovascular risk, and determining the effectiveness 
of intervention programs (14, 38). 
The endothelium is a dynamic paracrine organ made up of a single layer of cells 
and found between the lumen and the smooth muscle cells of blood vessels.  This layer of 
cells respond to physical and chemical signals by secreting factors that regulate vascular 
 75
   
tone, cellular adhesion, cell migration and proliferation, and vascular inflammation (6, 7).  
In healthy individuals, the quiescent state of the vascular system is maintained by 
vasoactive compounds released by endothelial cells, most notably nitric oxide (NO).  
Vascular shear stress that accompanies increased blood flow during exercise has been 
shown to stimulate the release of NO (20).  Chronic aerobic exercise training is known to 
decrease CVD risks and numerous studies have shown that vascular function improves 
with recurring bouts of aerobic exercise in both healthy individuals and those at higher risk 
of CVD (5, 10, 12, 13, 19, 28, 34, 36, 39).  Moreover, the improvement in vascular 
function following aerobic exercise training appears to be independent of any simultaneous 
improvement in CVD risk factors (11). 
Research supports the potential role of systemic inflammation in the 
pathophysiology of ED (4, 8, 17, 18, 22, 24, 35).  Obesity is characterized as a state of 
chronic low-grade inflammation and several circulating inflammatory markers, including 
tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6), are directly related to adiposity 
(4, 8, 17).  TNF-α has been shown to inhibit NO release from endothelial cells and degrade 
nitric oxide synthase mRNA, which can lead to an impairment of endothelium-dependent 
vasodilation (24, 35).  The role of IL-6 has recently received renewed attention as its origin 
of secretion is now thought to determine its function.  Whereas IL-6 released from adipose 
tissue is associated with an increase in the pro-inflammatory marker of C reactive protein 
(24), IL-6 secreted from contracting skeletal muscle is associated with the stimulation of 
anti-inflammatory cytokines and inhibition of TNF-α (22).  Although no studies have 
evaluated the extended time course of IL-6 and TNF-α following exercise, Louis and 
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colleagues demonstrated increased IL-6 and TNF-α mRNA changes in skeletal muscle up 
to 24 hours following an acute bout of exercise (18).        
Few studies have evaluated the effect of acute exercise on vascular function.  
Bousquet-Santos and colleagues measured forearm blood flow (FBF) and vascular 
reactivity (VR) in healthy sedentary volunteers for two hours following a maximal exercise 
bout (3).  VR was significantly elevated immediately after exercise and remained elevated 
for an hour before returning to baseline within two hours of exercise.  Likewise, Umpierre 
and colleagues measured FBF in stable chronic heart failure (CHF) patients and healthy 
controls up to 24 hours after a sub-maximal exercise bout (31).  No significant differences 
in FBF were observed between the groups across time and FBF had returned to baseline in 
both groups within one hour. 
The extended response of FBF and VR to maximal exercise in obese individuals 
has not been evaluated.  Therefore, the purpose of this study was to evaluate the FBF and 
VR changes in obese and non-obese males following a maximal aerobic exercise bout.  
Additionally, we evaluated the changes in blood markers associated with vascular 
endothelium activation following maximal exercise in both groups.       
Methods 
Subjects 
 
Twenty five male subjects between the ages of 19 and 29 years volunteered to 
participate in this study.  Subjects were categorized by their BMI into either a non-obese (n 
= 13, BMI ≤ 25 kg/m2) or obese (n = 12, BMI ≥ 30 kg/m2) group.  Subjects were excluded 
from the study if they were smokers, had been diagnosed with diabetes or high blood 
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pressure, had any form of known cardiovascular disease, or were taking medications that 
would potentially affect vascular function.  Subjects were also excluded if they were 
participating in high levels of physical activity as determined by the International Physical 
Activity Questionnaire at the time of the study.  Subjects were instructed to refrain from 
exercise for 3 days prior and alcohol and caffeine for 24 hour prior to the start of the study 
and during the course of the study.  Written informed consent was obtained from each 
subject before participation in the study. All procedures were approved by Virginia 
Commonwealth University’s Institutional Review Board.   
Study Design 
 
Subjects were instructed to report to the Human Performance Laboratory at 6:30 
a.m. following an overnight fast.  Subjects completed a medical history questionnaire and 
physical activity readiness questionnaire (PAR-Q) prior to the start of testing.  
Additionally, a physical activity diary was employed to evaluate physical activity outside 
of the study protocol.  After a 30-min rest period, a 7 ml blood sample was obtained from 
an anticubital vein.  Body composition was assessed with dual-energy x-ray 
absorptiometry (DXA; Lunar iDXA, GE Healthcare, Madison, WI).   Resting heart rate 
(HR), blood pressure (BP), and FBF measures were taken prior (PRE-E) to the maximal 
exercise test.  Blood samples and subsequent BP and FBF measures were taken 
immediately after exercise (POST-E) and 1 (POST-1), 2 (POST-2), 24 (POST-24), and 48 
(POST-48) hours after the cessation of exercise.  All FBF measures were taken on the right 
arm, opposite of all blood sampling.  All subjects were asked to remain in the laboratory 
until after the 2 hour post-exercise measurements.  On days 2 and 3, subjects reported to 
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the laboratory, following an overnight fast, 30 minutes prior to times corresponding to 24 
and 48 hours after the cessation of exercise, respectively.  A blood sample, BP, and FBF 
were taken following a 30-minute rest period.      
Maximal Exercise Protocol 
 
 Each subject was fitted with a heart rate monitor and respiratory gas analysis 
equipment (VMAX Spectra, Sensormedics Corp., Yorba Linda, CA) before completing a 
graded exercise test to exhaustion on a treadmill.  Following a 3-minute warm-up period, 
the treadmill speed was increased to elicit 80% of each individual’s age-predicted maximal 
heart rate within 4 minutes.  Thereafter, grade was increased by 2% every 2 minutes until 
the subject could no longer maintain the treadmill pace.  The protocol was designed to last 
8 – 12 minutes.  Heart rate was obtained every minute and rating of perceived exertion 
(RPE) was obtained once every exercise stage.  Following an immediate blood pressure 
measurement, a 1-minute post-exercise capillary blood lactate sample (Lactate Scout, 
Sports Resource Group, Inc) was obtained and used as a partial criterion to ensure that the 
subject gave a maximal effort.  Breath-by-breath oxygen consumption was averaged every 
10 seconds and the highest averaged value was identified as the maximal oxygen 
consumption (VO2max).   
Forearm Blood Flow Measurement 
 
Forearm blood flow (FBF) was assessed using mercury in-rubber strain gauge 
plethysmography (MSGP; Model AI6, D.E. Hokanson, Inc., Bellevue, WA).  Blood 
pressure cuffs were positioned around each subject’s upper right arm and right wrist, and a 
mercury-in-rubber strain gauge was placed around the forearm approximately 10 cm distal 
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to the olecranon process (1).  During each trial, the wrist cuff was inflated to a pressure of 
240 mmHg prior to each measurement to occlude hand circulation.  Baseline FBF was 
determined by rapidly inflating the upper cuff to 40 mmHg for 10 seconds to occlude 
venous flow during a 20 second cycle.  Nine measurements were recorded to determine the 
average rate of volume change during venous occlusion (ml/100 ml of forearm tissue 
volume/min).  Subsequently, the upper arm cuff was inflated to 240 mmHg to induce 
forearm ischemia for a period of 5 minutes.  After 5 minutes of occlusion, the cuff was 
released and FBF, as described above, was determined during a 3-minute period of reactive 
hyperemia (RH).  Area under the curve (AUC), calculated as a flow-time index, provided 
values for total FBF both at baseline and during RH.  Vascular reactivity (VR), indicated 
by total excess blood flow above baseline, was calculated as total FBF during RH minus 
total FBF at baseline.    
Biochemical Analyses 
 
Blood samples for analysis of TNF-α and IL-6 were collected into serum separator 
tubes and allowed to clot for 30 minutes before being centrifuged for 15 minutes at 1000 x 
g.  Serum was immediately aliquoted into microtubes and stored at -80°C until analyzed.  
Concentrations of tumor necrosis factor-α and interleukin-6 were determined through 
enzyme high-sensitivity immunoassay according to manufacturer’s specifications (R&D 
Systems, Minneapolis, MN).  All samples were analyzed in duplicate and the mean 
concentration of each sample was used during the statistical analysis. 
Statistical Analysis   
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 A mixed between-within repeated measures (RM) ANOVA (SPSS, Chicago, IL: 
V16.0) was used to determine the impact of a maximal exercise bout on systolic blood 
pressure (SBP), FBF, VR, and serum cytokine (IL-6 and TNF-α) concentration changes 
between the two groups (non-obese and obese males) across six different time periods 
(PRE-E, POST-E, POST-1, POST-2, POST-24, and POST-48).  If a main effect was 
observed within groups, a one-way ANOVA was used to determine differences across 
time, with a Bonferroni post-hoc analysis being performed to identify differences.  
Additionally, Pearson product-moment correlations were utilized to evaluate relationships 
among cardiorespiratory fitness values, vascular function, and cytokine (IL-6 and TNF-α) 
concentration responses following the maximal effort.  Subject demographics were 
compared using descriptive statistics and independent t-tests.  All data are expressed as 
mean ± SEM unless otherwise noted.  Statistical significance was set at P < 0.05. 
Results 
Subject Characteristics 
 Of the twenty-five subjects that volunteered for this study, one individual in the 
non-obese group requested to withdraw from the study due to an aversion to the blood 
sampling procedures.  Therefore, 12 subjects in both the non-obese and obese group were 
used in the final analyses.  Subject characteristics for both non-obese and obese males are 
presented in Table 1.  Body mass, BMI, body fat percentage, fat mass, fat-free mass, 
resting HR and SBP were significantly (P < 0.05) different between the groups.  
Additionally, PRE-E TNF-α concentration was significantly (P = 0.037) elevated in obese 
males compared to non-obese males.   
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Physiological variables in response to acute maximal exercise 
 Table 2 provides the physiological variables in response to the maximal exercise 
test.  The total duration of the maximal exercise test (not including warm-up) was 
significantly (P < 0.05) higher in the non-obese males compared to the obese males.  One 
non-obese male had difficulty breathing through the respiratory gas sensor.  The subject 
had the flow sensor removed during the maximal exercise test, however the subject 
continued with the protocol until expressing volitional fatigue.  Therefore, the non-obese 
group had 11 subjects for all VO2max data analyses.  VO2max expressed per kilogram of 
body mass and lean mass was significantly (P < 0.05) greater in non-obese males.  
Absolute VO2max was significantly (P < 0.05) greater in obese males.  Maximal lactate, 
RPE, and HR were similar in both groups. Furthermore, RM ANOVA revealed that SBP 
had significant main effects for group (P < 0.001) and time (P < 0.001).  A group x time 
interaction was not significant for SBP.  A one-way ANOVA revealed a significant (P < 
0.001) F-ratio for SBP across time for both groups.  Furthermore, a Bonferroni post-hoc 
analysis revealed that SBP was significantly elevated (P < 0.05) POST-E compared to 
PRE-E, before returning to values similar to PRE-E at POST-1, POST-2, POST-24, and 
POST-48.    
FBF in response to acute maximal exercise 
 The AUC for PRE-E FBF, at baseline and during RH, for both groups are shown in 
Figure 1.  As demonstrated in Figure 1, obese males had a significant elevation in FBF 
(Obese, 406.0 ± 32.8 ml/100 ml/min·sec vs. Non-obese, 271.4 ± 19.3 ml/100 ml/min·sec; P 
= 0.002) and FBF during RH (Obese, 714.8 ± 54.3 ml/100 ml/min·sec vs. Non-obese, 
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447.0 ± 51.0 ml/100 ml/min·sec; P = 0.002) at PRE-E measures.  RM ANOVA revealed 
that FBF, both at baseline and during RH, had significant main effects for group (Baseline 
FBF, P = 0.014; RH FBF, P = 0.013) and time (Baseline FBF, P = 0.001; RH FBF, P = 
0.001).  A group x time interaction was not significant for FBF at baseline or during RH.  
A one-way ANOVA revealed a significant (P < 0.001) F-ratio for FBF, at baseline and 
during RH, for both groups across time.  Furthermore, a Bonferroni post-hoc analysis 
revealed that FBF, at baseline and during RH, for both groups was significantly elevated 
(P < 0.05) POST-E compared to PRE-E, before returning to values similar to PRE-E at 
POST-1, POST-2, POST-24, and POST-48.   
VR, expressed as total excess blood flow above baseline, is shown in Figure 2.  RM 
ANOVA revealed that VR had significant main effects for group (P = 0.033) and time (P = 
0.026).  A group x time interaction was not significant for VR.  A one-way ANOVA 
revealed a significant (P = 0.014) F-ratio for VR across time for only non-obese males.  
Furthermore, a Bonferroni post-hoc analysis revealed that VR was significantly elevated (P 
= 0.017) POST-E compared to PRE-E in non-obese males.  VR remained elevated in non-
obese males, although not significantly different from PRE-E, at POST-1, POST-2, and 
POST-24 before returning to values at POST-48 significantly (P = 0.044) lower than 
POST-E.  In obese males, a one-way ANOVA revealed that VR was not significantly (P = 
0.497) different across time.  As demonstrated figure 2, an independent sample t-test 
revealed a significantly higher VR PRE-E in obese males compared to non-obese males 
(308.8 ± 29.7 ml/100 ml/min·sec vs. 175.5 ± 38.7 ml/100 ml/min·sec, P = 0.012).   
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The VR measures across time were significantly correlated to observed SBP across 
time (r = 0.359, P < 0.001).  Furthermore, VR PRE-E was not significantly correlated to 
VO2max per lean muscle mass (r = -0.207, P = 0.343).  However, VR PRE-E was 
significantly correlated to BMI (r = .475, P = 0.019), fat mass (r = 0.446, P = 0.029), lean 
mass (r = 0.527, P = 0.008), and percent fat (r = 0.508, P = 0.011).  Figure 3 illustrates the 
relation between VR and percent fat. 
IL-6 and TNF-α response to acute maximal exercise 
 One non-obese male did not have a blood sample collected at 1 hour post exercise 
and one obese male had an undetectable IL-6 concentration at 24 hours post exercise.  
Therefore, the non-obese group had 11 subjects for IL-6 and TNF-α analysis at 1 hour post 
exercise and the obese group had 11 subjects for IL-6 analyses at 24 hours post exercise.  
Although IL-6 was not significantly different between groups at PRE-E, TNF-α was 
significantly (P = 0.037) elevated in obese compared to non-obese males (Table 1).  RM 
ANOVA revealed that IL-6 had a significant main effect for group (P = 0.032) and time (P 
= 0.008).  A group x time interaction was not significant with IL-6.  A one-way ANOVA 
revealed a significant (P = .014) F-ratio for IL-6 across time for only obese males.  A 
Bonferroni post-hoc analysis did not reveal any differences in IL-6 across time in obese 
males.  However, a paired-sample T-test between the non-obese and obese male’s peak IL-
6 (POST-2) and lowest IL-6 (POST-48) revealed a significant reduction (P < 0.05) of 
57.63 and 66.82%, respectively.       
Additionally, RM ANOVA revealed that TNF-α had a significant main effect for 
group (P = 0.017) and time (P = 0.027).  A group x time interaction was not significant 
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with TNF-α.  A one-way ANOVA with TNF-α samples from all males combined revealed 
a non-significant (P = 0.786) F-ratio across time.  Additionally, when TNF-α was 
compared within non-obese and obese males, a one-way ANOVA revealed a non-
significant F-ratio for non-obese (P = 0.653) and obese males (P = 0.978) across time.        
Furthermore, VR, BMI, percent fat, and fat mass were not significantly correlated 
to IL-6 or TNF-α.  The mean coefficient of variation for all IL-6 and TNF-α samples run 
was 16.0 ± 1.3% and 9.9 ± 0.6%, respectively.   
Discussion 
 This is the first study that evaluated FBF and VR in obese males after a single 
maximal bout of aerobic exercise.  The main finding in this study was that a single 
maximal bout of aerobic exercise resulted in an immediate post-exercise significant 
increase in VR in non-obese individuals only.  Although obese individuals did not 
demonstrate a significant increase in VR following a single maximal bout of exercise, the 
VR response following exercise was not significantly different between non-obese and 
obese males.  FBF response to exercise was not significantly different at baseline and 
during RH between non-obese and obese males.  FBF and FBF during RH significantly 
increased in both groups immediately after exercise, before returning to PRE-E levels 
within 1 hour of exercise.    
 Furthermore, the exercise response of IL-6 and TNF-α was not significantly 
different in non-obese and obese males.  The magnitude of change in IL-6 at POST-48 
from POST-2 was greater in obese males.  No response was observed in TNF-α for up to 
48 hours following a single bout of maximal exercise in non-obese and obese males.     
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 Similar to previous studies, following an acute aerobic exercise bout, our study 
revealed an increase in FBF and VR immediately following exercise (2, 3, 15, 32).  
Kingwell and colleagues demonstrated an increase in FBF immediately following 30 
minutes of cycling at 65% of VO2max in healthy individuals (15).  However, it is unclear 
how long the increase in FBF lasted after exercise, as the investigators only showed results 
from three subjects who continued to have an increased FBF at 60 minutes post exercise.  
FBF and VR have been measured after a maximal exercise test in only two other studies.  
Bousquet-Santos and colleagues demonstrated a significant increase in FBF during RH and 
VR immediately following a maximal exercise test in healthy sedentary individuals (3).  
The increase in FBF during RH and VR were still significantly elevated at 1 hour post 
exercise before returning to baseline levels within 2 hours post exercise.  Baynard and 
colleagues evaluated the difference in FBF during RH in resistance trained versus 
endurance trained men following a maximal exercise test (2).  Similar to our study, there 
were significant differences in VO2max and testing time when comparing the two groups.  
FBF during RH was significantly elevated after exercise, although no differences were 
shown between the two groups both prior to and following exercise.  However, Baynard 
and colleagues did not report the FBF after exercise, which would have allowed for 
differentiation of improved VR or vascular conductance after exercise (2).   
 ED has been associated with obesity, as well as the progression of CHF (30, 37).  
In a recent study, Umpierre and colleagues evaluated the difference in FBF and FBF 
during RH following a sub-maximal cycle test in CHF patients versus healthy controls 
(31).  There were no significant differences in FBF or FBF during RH between the CHF 
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patients and healthy controls prior to exercise (31).  FBF following exercise had a similar 
temporal response between the two groups.  FBF was significantly elevated after the 
exercise session and returned to pre-exercise values within 1 hour after exercise.  FBF 
during RH was significantly elevated in both groups at 30 minutes post-exercise and 
significantly different between CHF patients and healthy controls.  Although our FBF 
during RH response was not significantly different between non-obese and obese males 
immediately following exercise, we did not measure FBF at 30 minutes post-exercise in 
non-obese and obese males.  These findings between CHF patients and healthy controls, in 
which a difference in endothelium-dependent vasodilation is expected across groups, were 
similar to our findings.  In our study, although the magnitude of change in VR was higher 
in non-obese males, our obese males presented normal endothelium-dependent 
vasodilation following a single maximal aerobic bout of exercise.  Additionally, this study 
is the first to demonstrate an enhanced vascular conductance in obese males immediately 
following a maximal bout of exercise.  An increased vascular conductance immediately 
after exercise had previously been shown in non-obese healthy individuals (3). 
 Although IL-6 was not significantly different at baseline between our non-obese 
and obese males, TNF-α was significantly elevated in obese males at pre-exercise levels.  
While both markers have been shown to be significantly correlated with adiposity levels, 
Van Guilder and colleagues suggested that this correlation is only present among obese 
individuals who also have the metabolic syndrome (MetS) (24, 26, 33).  Although a 
mechanism responsible for the difference in obese individuals with and without MetS is 
unknown, obese individuals without MetS had similar baseline concentrations of IL-6 and 
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TNF-α to that of normal weight individuals (33).  In the current study, we did not access 
the presence of the MetS in our obese males.  However, the similarity in IL-6 and TNF-α 
previously reported between normal weight individuals and obese individuals without the 
MetS may help explain the current study’s similar temporal response to IL-6 and TNF-α 
following exercise in non-obese and obese males.  Additionally, it has previously been 
reported that IL-6 and TNF-α significantly increase following a maximal bout of exercise 
(16).  In spite of these earlier findings, IL-6 and TNF-α did not significantly increase 
following exercise in our study.  However, it is important to note that in both groups, there 
was a significant reduction between the highest IL-6 concentration (POST-2) and lowest 
IL-6 concentration (POST-48).  Although we do not know the origin of secretion for the 
IL-6 measured in this study, these results potentially demonstrate an anti-inflammatory 
effect of muscle derived IL-6 following maximal exercise.  It is important to note that we 
did not take a sample of blood between POST and 1 hour after exercise and are unable to 
conclude that a shortened response did not occur within our measurement periods.  
Furthermore, the IL-6 and TNF-α response to acute exercise led us to believe that FBF and 
VR at rest and following a single maximal aerobic bout of exercise are independent of 
these blood markers in non-obese and obese males. 
These results must be viewed within the context of this study’s limitations.  Studies 
have demonstrated with an infusion of a NO inhibitor, such as NG-monomethyl-L-arginine 
(L-NMMA), that FBF is dependent on NO bioavailability in both sedentary and trained 
individuals (13, 15).  Shear stress, generated by flow during exercise and RH, is one of the 
most important mechanical regulators of endothelial NO synthase (9).  Although we did 
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not measure shear stress or NO metabolites, we can not discount that a difference in shear 
stress may have contributed to the distinct VR magnitude changes observed between non-
obese and obese males after exercise.  Conversely, we also did not measure the size of the 
arteries in the forearm under investigation.  Rognmo and colleagues speculated that lower 
fitness levels were often associated with smaller arteries that may have a greater vascular 
dilation response due to an increased hyperemic shear stress (25).  Our non-obese males 
had a significantly lower cardiorespiratory fitness level, demonstrated by a lower VO2max 
per FFM.  The significantly enhanced FBF and FBF during RH in obese males may have 
been attributed to a smaller artery size and subsequent enhanced hyperemic shear stress.  
This is further illustrated by the significant main effect for SBP between groups, in which 
SBP was elevated in obese individuals across all time points.  Lastly, there were no FBF 
measurements between the end of exercise and 1 hour following exercise.  As described 
above, changes in FBF following exercise may have occurred within the first hour after 
exercise (31).   
In conclusion, a single maximal aerobic bout of exercise results in increased FBF, 
at baseline and during RH, in non-obese and obese males.  Additionally, non-obese males 
had a greater magnitude change than obese males in VR immediately following exercise.  
These changes in FBF and VR following exercise demonstrate that although non-obese 
and obese males have an increased vascular conductance immediately after exercise, only 
non-obese males have a significantly enhanced reactive vasodilation following exercise.  
TNF-α did not change in response to a single maximal bout of exercise and does not 
further explain the changes seen in FBF following the exercise session.  Likewise, 
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although the response of IL-6 to maximal exercise was not significantly different between 
non-obese and obese males, both groups demonstrated a significant reduction in IL-6 at 
peak values, 2 hours post-exercise, compared to 48 hours post-exercise.  This change could 
help explain an anti-inflammatory effect of muscle-derived IL-6.  However, the IL-6 
response to exercise did not explain the observed response to FBF following the exercise 
session.  Future studies are warranted that investigate the acute effects of various exercise 
intensities and VR measurement times in non-obese and obese individuals. 
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Table 1 Subject characteristics 
Variable      Non-Obese           Obese   
Age (years)                 21.6 ± 0.4        23.0 ± 1.0 
Weight (kg)                          67.8 ± 2.8*      121.3 ± 5.0 
BMI (kg/m2)      21.9 ± 0.3*        37.0 ± 1.1 
Percent Fat (%)     19.8 ± 1.4*        41.3 ± 1.6 
Fat Mass (kg)      13.0 ± 1.2*        48.5 ± 3.5 
Lean Mass (kg)     51.9 ± 1.9*        67.9 ± 2.5 
Resting HR (bmp)     56.0 ± 2.2*        64.0 ± 2.9 
Resting SBP (mm Hg)             119.3 ± 4.2*      134.6 ± 3.2 
Resting DBP (mm Hg)    66.6 ± 2.1        73.0 ± 2.7 
Baseline IL-6 (pg/mL)                 1.4 ± 0.5          1.7 ± 0.5 
Baseline TNF-α (pg/mL)      1.3 ± 0.1*          1.7 ± 0.2  
* P < 0.05, Non-obese vs. Obese.  Values are mean ± SEM. 
BMI, Body Mass Index; HR, Heart Rate; SBP, Systolic Blood Pressure; DBP, Diastolic 
Blood Pressure; IL, Interleukin; TNF-α, Tumor Necrosis Factor alpha. 
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Table 2 Physiological variables in response to acute maximal exercise 
Variable      Non-Obese           Obese   
Maximal Lactate (mmol/L)               10.6 ± 0.7          9.9 ± 0.7 
Maximal RPE                          19.5 ± 0.1        19.1 ± 0.2 
Maximal HR (bpm)              195.9 ± 2.3      197.0 ± 1.7 
Test Duration (s)              709.9 ± 33.6*      545.0 ± 20.7 
Relative VO2max (mLO2/kg of BW/min)  50.9 ± 1.1*        34.8 ± 1.2 
Relative VO2max (mLO2/kg of LM/min)  66.1 ± 1.2*        61.8 ± 1.6 
Absolute VO2max (LO2/min)      3.4 ± 0.1*          4.1 ± 0.1 
* P < 0.05, Non-obese vs. Obese.  Values are mean ± SEM. 
RPE, Rating of Perceived Exertion; HR, Heart Rate; VO2max, Maximal Oxygen 
Consumption; BW, Body Weight; LM, Lean Mass.  
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Figure 1.  PRE-E Forearm blood flow calculated as the area under the curve (mean ± 
SEM).  *p<0.05 Non-obese vs. Obese 
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Figure 2.  Vascular reactivity, calculated as total RH FBF minus total baseline FBF (mean 
± SEM).  #p<0.05, PRE-E, Obese vs. Non-obese; *p<0.05, Non-obese, POST-E  vs. PRE-
E; †p<0.05, Non-obese, POST-48 vs. POST-E.   
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Figure 3. Relation between VR PRE-E and Percent Fat (r = 0.508, P = 0.011). 
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APPENDIX A 
 
Expanded Methods 
Subjects 
 
Forty male subjects between the ages of 18 and 30 years with body mass index 
(BMI) values below 25 kg/m2 (N = 20) and greater than 30 kg/m2 (N = 20) were recruited 
for the study through flyers posted on campus and through classroom visits.  All classroom 
visits were approved by the instructor and/or department chair.  Classroom visits lasted 
less than 5 minutes and consisted of a research staff member describing the project and 
answering any questions posed by potential subjects.  Potential subjects were not 
encouraged to make their interest in participating known during the classroom visit, but 
were given a contact number for the Health and Human Performance Laboratory so that 
contact could be made at a later time.  Potential subjects were made aware that their 
participation was completely voluntary and that the course instructor would not be made 
aware of who did or did not participate in the project.   
Twenty five male subjects between the ages of 19 and 29 years volunteered to 
participate in this study.  Subjects were categorized by their BMI into either a non-obese (n 
= 13, BMI ≤ 25 kg/m2) or obese (n = 12, BMI ≥ 30 kg/m2) group.  Subjects were excluded 
from the study if they were smokers, had been diagnosed with diabetes or high blood 
pressure, had any form of known cardiovascular disease, or were taking medications that 
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would potentially affect vascular function.  Subjects were also excluded if they were 
participating in high levels of physical activity as determined by the International Physical 
Activity Questionnaire (IPAQ) at the time of the study.  The IPAQ is a short (4 questions), 
7-day physical activity recall for use with young and middle-aged adults.  The types of 
activity assessed in the IPAQ short include walking, moderate-intensity and vigorous-
intensity activities.  The amount of activity for each type assessed was given a separate 
score that required the summation of the duration (minutes) and frequency (days).  
Walking, moderate-intensity, and vigorous-intensity were designated MET values of 3.3, 
4.0, and 8.0 respectively.  High physical activity consisted of individuals meeting one of 2 
criteria: 1.) Vigorous-intensity activity on at least 3 days and accumulating at least 1,500 
MET-minutes/week or 2.) 7 or more days of any combination of walking, moderate- or 
vigorous-intensity activities accumulating at least 3,000 MET-minutes/week.  Subjects 
were instructed to refrain from exercise for 3 days prior and alcohol and caffeine for 24 
hour prior to the start of the study and during the course of the study.  Written informed 
consent was obtained from each subject before participation in the study. All procedures 
were approved by Virginia Commonwealth University’s Institutional Review Board.   
Study Design 
 
Subjects were instructed to report to the Human Performance Laboratory at 6:30 
a.m. following an overnight fast.  Subjects completed a medical history questionnaire and 
physical activity readiness questionnaire (PAR-Q) prior to the start of testing.  
Additionally, a physical activity diary was employed to evaluate physical activity outside 
of the study protocol.  After a 30-min rest period, a 7 ml blood sample was obtained from 
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an anticubital vein.  Body composition was assessed with dual-energy x-ray 
absorptiometry (DXA; Lunar iDXA, GE Healthcare, Madison, WI).   Resting heart rate 
(HR), blood pressure (BP), and FBF measures were taken prior (PRE-E) to the maximal 
exercise test.  Blood samples and subsequent BP and FBF measures were taken 
immediately after exercise (POST-E) and 1 (POST-1), 2 (POST-2), 24 (POST-24), and 48 
(POST-48) hours after the cessation of exercise.  All FBF measures were taken on the right 
arm, opposite of all blood sampling.  All subjects were asked to remain in the laboratory 
until after the 2 hour post-exercise measurements.  On days 2 and 3, subjects reported to 
the laboratory, following an overnight fast, 30 minutes prior to times corresponding to 24 
and 48 hours after the cessation of exercise, respectively.  A blood sample, BP, and FBF 
were taken following a 30-minute rest period.      
Maximal Exercise Protocol 
 
 Each subject was fitted with a heart rate monitor and respiratory gas analysis 
equipment (VMAX Spectra, Sensormedics Corp., Yorba Linda, CA) before completing a 
graded exercise test to exhaustion on a treadmill.  Following a 3-minute warm-up period (3 
mph at 0% grade), the treadmill speed was increased to elicit 80% of each individual’s age-
predicted maximal heart rate within 4 minutes.  Thereafter, grade was increased by 2% 
every 2 minutes until the subject could no longer maintain the treadmill pace.  The 
protocol was designed to last 8 – 12 minutes.  Heart rate was obtained every minute and 
rating of perceived exertion (RPE) was obtained once every exercise stage.  Following an 
immediate blood pressure measurement, a 1-minute post-exercise capillary blood lactate 
sample (Lactate Scout, Sports Resource Group, Inc) was obtained and used as a partial 
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criterion to ensure that the subject gave a maximal effort.  Breath-by-breath oxygen 
consumption was averaged every 10 seconds and the highest averaged value was identified 
as the maximal oxygen consumption (VO2max).   
Forearm Blood Flow Measurement 
 
Forearm blood flow (FBF) was assessed using mercury in-rubber strain gauge 
plethysmography (MSGP; Model AI6, D.E. Hokanson, Inc., Bellevue, WA).  Blood 
pressure cuffs were positioned around each subject’s upper right arm and right wrist, and a 
mercury-in-rubber strain gauge was placed around the forearm approximately 10 cm distal 
to the olecranon process (1).  During each trial, the wrist cuff was inflated to a pressure of 
240 mmHg prior to each measurement to occlude hand circulation.  Baseline FBF was 
determined by rapidly inflating the upper cuff to 40 mmHg for 10 seconds to occlude 
venous flow during a 20 second cycle.  Nine measurements were recorded to determine the 
average rate of volume change during venous occlusion (ml/100 ml of forearm tissue 
volume/min).  Subsequently, the upper arm cuff was inflated to 240 mmHg to induce 
forearm ischemia for a period of 5 minutes.  After 5 minutes of occlusion, the cuff was 
released and FBF, as described above, was determined during a 3-minute period of reactive 
hyperemia (RH).  Each measurement period was edited one at a time.  Area under the 
curve (AUC), calculated as a flow-time index, provided values for total FBF both at 
baseline and during RH.  Flow-time index was calculated as the summation of two 
consecutive time periods, divided by 2 and multiplied by the measurement time (20 
seconds).  Vascular reactivity (VR), indicated by total excess blood flow above baseline, 
was calculated as total FBF during RH minus total FBF at baseline. 
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Biochemical Analyses 
 
Blood samples for analysis of TNF-α and IL-6 were collected into serum separator 
tubes and allowed to clot for 30 minutes before being centrifuged for 15 minutes at 1000 x 
g.  Serum was immediately aliquoted into microtubes and stored at -80°C until analyzed.  
Concentrations of tumor necrosis factor-α and interleukin-6 were determined through 
enzyme high-sensitivity immunoassay according to manufacturer’s specifications (R&D 
Systems, Minneapolis, MN).   
Masks and gloves were worn during the preparation of all assay kits as a 
precautionary measure.  Distilled water was used to prepare a wash buffer.  Specifications 
of plate washer were set as follows: 
Plate: R&D Systems 
Bottom Shape: Flat 
Centering: 0.8 mm 
Asp. Hor. Pos.: 2.0 mm 
Asp. Vert. Pos.: 12.0 mm 
Bot. Vert. Pos.: 11.0 mm 
B.W. Vert. Pos.: 9.0 mm 
Horizontal Speed: 4 
Vertical Speed: 4 
Asp. Downw. Speed: 0 
Disp. Upw. Speed: 2 
Bot. Downw. Speed: 6 
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Bot. Upward Speed: 9 
Shaking Amplitude: 0 
Shaking Speed: 0 
Kit: R&D Systems 
 Method 1: Wash 
 Mode: Plate 
 Crosw. Asp.: No 
 Asp. Time: 1.0 s 
 Volume: 400 μl 
 Overflow: 3.2 mm 
 Liquid: Wash W1 
 Flow: 00 
 Nr. Of Cycles: 6 
 Soaking: 30 s 
 Met. Intervals: 0 m 0 s 
 Method 2: Asp. 
 Mode: Plate   
 Crosw. Asp.: No 
 Asp. Time: 1.5 s 
 Nr. Of Cycles: 1 
 Soaking: 0 m 0 s 
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 Serum cytokine concentration was determined using a microplate reader (Model 
680 XR, Bio-Rad Laboratories, Inc., Hercules, CA).  The reading parameters for the 
endplate protocol were set 490 nm (measurement filter) and 650 nm (reference filter).  All 
samples were analyzed in duplicate and the mean concentration of each sample was used 
during the statistical analysis. 
Statistical Analysis   
 
 A mixed between-within repeated measures (RM) ANOVA (SPSS, Chicago, IL: 
V16.0) was used to determine the impact of a maximal exercise bout on systolic blood 
pressure (SBP), FBF, VR, and serum cytokine (IL-6 and TNF-α) concentration changes 
between the two groups (non-obese and obese males) across six different time periods 
(PRE-E, POST-E, POST-1, POST-2, POST-24, and POST-48).  If a main effect was 
observed within groups, a one-way ANOVA was used to determine differences across 
time, with a Bonferroni post-hoc analysis being performed to identify differences.  
Additionally, Pearson product-moment correlations were utilized to evaluate relationships 
among cardiorespiratory fitness values, vascular function, and cytokine (IL-6 and TNF-α) 
concentration responses following the maximal effort.  Subject demographics were 
compared using descriptive statistics and independent t-tests.  All data are expressed as 
mean ± SEM unless otherwise noted.  Statistical significance was set at P < 0.05. 
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